<!DOCTYPE sequence-cwu SYSTEM "us-sequence-listing-2004-03-09.dtd" [ ]>
<sequence-cwu id="SEQLST-1">
<publication-reference>
<document-id>
<country>US</country>
<doc-number>08623611</doc-number>
<kind>B2</kind>
<date>20140107</date>
</document-id>
</publication-reference>
<number>1</number>
<sequence-list-new-rules>
<s100>
<s160>623</s160>
</s100>
<s200>
<s210>1</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 1
Ala Asp Glu Gly Ile Ser Phe Arg
1               5
</s400>
<s200>
<s210>2</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 2
Gln Ile Thr Val Asn Asp Leu Pro Val Gly Arg
1               5                   10
</s400>
<s200>
<s210>3</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 3
Asn Phe Pro Ser Pro Val Asp Ala Ala Phe Arg
1               5                   10
</s400>
<s200>
<s210>4</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 4
Leu Leu Gln Asp Glu Phe Pro Gly Ile Pro Ser Pro Leu Asp Ala Ala
1               5                   10                  15
Val Glu Cys His Arg
            20
</s400>
<s200>
<s210>5</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 5
Tyr Tyr Cys Phe Gln Gly Asn Gln Phe Leu Arg
1               5                   10
</s400>
<s200>
<s210>6</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 6
Gly Gly Tyr Thr Leu Val Ser Gly Tyr Pro Lys
1               5                   10
</s400>
<s200>
<s210>7</s210>
<s211>24</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 7
Glu Val Gly Thr Pro His Gly Ile Ile Leu Asp Ser Val Asp Ala Ala
1               5                   10                  15
Phe Ile Cys Pro Gly Ser Ser Arg
            20
</s400>
<s200>
<s210>8</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 8
Arg Leu Trp Trp Leu Asp Leu Lys
1               5
</s400>
<s200>
<s210>9</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 9
Ser Gly Ala Gln Ala Thr Trp Thr Glu Leu Pro Trp Pro His Glu Lys
1               5                   10                  15
</s400>
<s200>
<s210>10</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 10
Asp Gln Gly Pro Asn Val Cys Ala Leu Gln Gln Ile Leu Gly Thr Lys
1               5                   10                  15
</s400>
<s200>
<s210>11</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 11
Leu Arg Glu Glu Ile Glu Gly Lys
1               5
</s400>
<s200>
<s210>12</s210>
<s211>23</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 12
Val Leu Thr Gln Ile Gly Thr Ser Ile Gln Asp Phe Ile Glu Ala Glu
1               5                   10                  15
Asp Asp Leu Ser Ser Phe Arg
            20
</s400>
<s200>
<s210>13</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 13
Ala Ala Ala Ile Thr Ser Asp Ile Leu Glu Ala Leu Gly Arg
1               5                   10
</s400>
<s200>
<s210>14</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 14
Asp Gly His Phe Thr Leu Phe Ala Pro Thr Asn Glu Ala Phe Glu Lys
1               5                   10                  15
</s400>
<s200>
<s210>15</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 15
Asp Ile Val Thr Asn Asn Gly Val Ile His Leu Ile Asp Gln Val Leu
1               5                   10                  15
Ile Pro Asp Ser Ala Lys
            20
</s400>
<s200>
<s210>16</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 16
Val Gly Leu Asn Glu Leu Tyr Asn Gly Gln Ile Leu Glu Thr Ile Gly
1               5                   10                  15
Gly Lys
</s400>
<s200>
<s210>17</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 17
Phe Ser Thr Phe Leu Ser Leu Leu Glu Ala Ala Asp Leu Lys
1               5                   10
</s400>
<s200>
<s210>18</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 18
Glu Leu Leu Thr Gln Pro Gly Asp Trp Thr Leu Phe Val Pro Thr Asn
1               5                   10                  15
Asp Ala Phe Lys
            20
</s400>
<s200>
<s210>19</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 19
Leu Leu Tyr Pro Ala Asp Thr Pro Val Gly Asn Asp Gln Leu Leu Glu
1               5                   10                  15
Ile Leu Asn Lys
            20
</s400>
<s200>
<s210>20</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 20
Ile Ile Asp Gly Val Pro Val Glu Ile Thr Glu Lys
1               5                   10
</s400>
<s200>
<s210>21</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 21
Asp Ser Pro Ser Val Trp Ala Ala Val Pro Gly Lys
1               5                   10
</s400>
<s200>
<s210>22</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 22
Thr Phe Val Asn Ile Thr Pro Ala Glu Val Gly Val Leu Val Gly Lys
1               5                   10                  15
</s400>
<s200>
<s210>23</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 23
Val Gly Leu Val Gln Phe Ser Asp Thr Pro Val Thr Glu Phe Ser Leu
1               5                   10                  15
Asn Thr Tyr Gln Thr Lys
            20
</s400>
<s200>
<s210>24</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 24
Ser Asp Ile Leu Gly His Leu Arg
1               5
</s400>
<s200>
<s210>25</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 25
Thr Leu Ser Gly Thr Pro Glu Glu Ser Lys Arg
1               5                   10
</s400>
<s200>
<s210>26</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 26
Ala Ala Pro Leu Gln Gly Leu Pro Gly Leu Leu Ala Pro Leu Arg
1               5                   10                  15
</s400>
<s200>
<s210>27</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 27
Leu Leu Pro Tyr Ile Val Gly Val Ala Gln Arg
1               5                   10
</s400>
<s200>
<s210>28</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 28
Met Lys Pro Leu Asp Gly Ser Ala Leu Tyr Thr Gly Ser Ala Leu Asp
1               5                   10                  15
Phe Val Arg
</s400>
<s200>
<s210>29</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 29
Asn Asn Leu Phe Thr Ser Ser Ala Gly Tyr Arg
1               5                   10
</s400>
<s200>
<s210>30</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 30
Leu Leu Val Leu Ile Thr Gly Gly Lys
1               5
</s400>
<s200>
<s210>31</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 31
Ser Leu Asp Glu Ile Ser Gln Pro Ala Gln Glu Leu Lys
1               5                   10
</s400>
<s200>
<s210>32</s210>
<s211>24</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 32
Gly Ala Asp Gln Ala Glu Leu Glu Glu Ile Ala Phe Asp Ser Ser Leu
1               5                   10                  15
Val Phe Ile Pro Ala Glu Phe Arg
            20
</s400>
<s200>
<s210>33</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 33
Asp Ile Leu Phe Leu Phe Asp Gly Ser Ala Asn Leu Val Gly Gln Phe
1               5                   10                  15
Pro Val Val Arg
            20
</s400>
<s200>
<s210>34</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 34
Ile Ile Asp Glu Leu Asn Val Lys Pro Glu Gly Thr Arg
1               5                   10
</s400>
<s200>
<s210>35</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 35
Ile Ala Val Ala Gln Tyr Ser Asp Asp Val Lys Val Glu Ser Arg
1               5                   10                  15
</s400>
<s200>
<s210>36</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 36
Phe Asp Glu His Gln Ser Lys Pro Glu Ile Leu Asn Leu Val Lys
1               5                   10                  15
</s400>
<s200>
<s210>37</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 37
Ala Leu Asn Leu Gly Tyr Ala Leu Asp Tyr Ala Gln Arg
1               5                   10
</s400>
<s200>
<s210>38</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 38
Ser Ser Asp Arg Val Asp Gly Pro Ala Ser Asn Leu Lys
1               5                   10
</s400>
<s200>
<s210>39</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 39
Val Asp Gly Pro Ala Ser Asn Leu Lys
1               5
</s400>
<s200>
<s210>40</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 40
Gln Ser Gly Val Val Pro Phe Ile Phe Gln Ala Lys
1               5                   10
</s400>
<s200>
<s210>41</s210>
<s211>25</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 41
Asn Ala Asp Pro Ala Glu Leu Glu Gln Ile Val Leu Ser Pro Ala Phe
1               5                   10                  15
Ile Leu Ala Ala Glu Ser Leu Pro Lys
            20                  25
</s400>
<s200>
<s210>42</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 42
Ile Gly Asp Leu His Pro Gln Ile Val Asn Leu Leu Lys
1               5                   10
</s400>
<s200>
<s210>43</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 43
Asp Val Val Phe Leu Leu Asp Gly Ser Glu Gly Val Arg
1               5                   10
</s400>
<s200>
<s210>44</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 44
Ser Gly Phe Pro Leu Leu Lys
1               5
</s400>
<s200>
<s210>45</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 45
Val Val Glu Ser Leu Asp Val Gly Gln Asp Arg
1               5                   10
</s400>
<s200>
<s210>46</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 46
Val Ala Val Val Gln Tyr Ser Asp Arg
1               5
</s400>
<s200>
<s210>47</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 47
Gln Leu Thr Leu Leu Gly Gly Pro Thr Pro Asn Thr Gly Ala Ala Leu
1               5                   10                  15
Glu Phe Val Leu Arg
            20
</s400>
<s200>
<s210>48</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 48
Asn Ile Leu Val Ser Ser Ala Gly Ser Arg
1               5                   10
</s400>
<s200>
<s210>49</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 49
Ile Thr Glu Gly Val Pro Gln Leu Leu Ile Val Leu Thr Ala Asp Arg
1               5                   10                  15
</s400>
<s200>
<s210>50</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 50
Ser Gly Asp Asp Val Arg Asn Pro Ser Val Val Val Lys
1               5                   10
</s400>
<s200>
<s210>51</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 51
Gln Leu Gly Thr Val Gln Gln Val Ile Ser Glu Arg
1               5                   10
</s400>
<s200>
<s210>52</s210>
<s211>6</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 52
Val Thr Gln Leu Thr Arg
1               5
</s400>
<s200>
<s210>53</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 53
Leu Gln Pro Val Leu Gln Pro Leu Pro Ser Pro Gly Val Gly Gly Lys
1               5                   10                  15
</s400>
<s200>
<s210>54</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 54
Asp Val Val Phe Leu Ile Asp Gly Ser Gln Ser Ala Gly Pro Glu Phe
1               5                   10                  15
Gln Tyr Val Arg
            20
</s400>
<s200>
<s210>55</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 55
Leu Val Asp Tyr Leu Asp Val Gly Phe Asp Thr Thr Arg
1               5                   10
</s400>
<s200>
<s210>56</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 56
Val Ala Val Ile Gln Phe Ser Asp Asp Pro Lys
1               5                   10
</s400>
<s200>
<s210>57</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 57
Val Glu Phe Leu Leu Asn Ala His Ser Ser Lys Asp Glu Val Gln Asn
1               5                   10                  15
Ala Val Gln Arg
            20
</s400>
<s200>
<s210>58</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 58
Asp Glu Val Gln Asn Ala Val Gln Arg
1               5
</s400>
<s200>
<s210>59</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 59
Gln Ile Asn Val Gly Asn Ala Leu Glu Tyr Val Ser Arg
1               5                   10
</s400>
<s200>
<s210>60</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 60
Ile Glu Glu Gly Val Pro Gln Phe Leu Val Leu Ile Ser Ser Gly Lys
1               5                   10                  15
</s400>
<s200>
<s210>61</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 61
Ser Asp Asp Glu Val Asp Asp Pro Ala Val Glu Leu Lys
1               5                   10
</s400>
<s200>
<s210>62</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 62
Gln Phe Gly Val Ala Pro Phe Thr Ile Ala Arg
1               5                   10
</s400>
<s200>
<s210>63</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 63
Asn Ala Asp Gln Glu Glu Leu Val Lys
1               5
</s400>
<s200>
<s210>64</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 64
Ile Ser Leu Ser Pro Glu Tyr Val Phe Val Ser Thr Phe Arg
1               5                   10
</s400>
<s200>
<s210>65</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 65
Leu Leu Thr Pro Ile Thr Thr Leu Thr Ser Glu Gln Ile Gln Lys
1               5                   10                  15
</s400>
<s200>
<s210>66</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 66
Arg Leu Asn Ile Gly Pro Ser Lys
1               5
</s400>
<s200>
<s210>67</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 67
Leu Asn Ile Gly Pro Ser Lys
1               5
</s400>
<s200>
<s210>68</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 68
Val Gly Val Val Gln Phe Ser Asn Asp Val Phe Pro Glu Phe Tyr Leu
1               5                   10                  15
Lys
</s400>
<s200>
<s210>69</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 69
Ser Gln Ala Pro Val Leu Asp Ala Ile Arg
1               5                   10
</s400>
<s200>
<s210>70</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 70
Ala Leu Glu Phe Val Ala Arg
1               5
</s400>
<s200>
<s210>71</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 71
Ile Glu Asp Gly Val Pro Gln His Leu Val Leu Val Leu Gly Gly Lys
1               5                   10                  15
</s400>
<s200>
<s210>72</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 72
Ser Ser Gly Ile Val Ser Leu Gly Val Gly Asp Arg
1               5                   10
</s400>
<s200>
<s210>73</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 73
Asn Ile Asp Arg Thr Glu Leu Gln Thr Ile Thr Asn Asp Pro Arg
1               5                   10                  15
</s400>
<s200>
<s210>74</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 74
Thr Glu Leu Gln Thr Ile Thr Asn Asp Pro Arg
1               5                   10
</s400>
<s200>
<s210>75</s210>
<s211>6</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 75
Leu Val Phe Thr Val Arg
1               5
</s400>
<s200>
<s210>76</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 76
Asp Ser Phe Gln Glu Val Leu Arg
1               5
</s400>
<s200>
<s210>77</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 77
Arg Gln Ile Ile Asp Ala Ile Asn Lys
1               5
</s400>
<s200>
<s210>78</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 78
Val Gly Leu Glu His Leu Arg
1               5
</s400>
<s200>
<s210>79</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 79
Val Asn His Phe Val Pro Glu Ala Gly Ser Arg
1               5                   10
</s400>
<s200>
<s210>80</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 80
Val Pro Gln Ile Ala Phe Val Ile Thr Gly Gly Lys
1               5                   10
</s400>
<s200>
<s210>81</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 81
Ser Val Glu Asp Ala Gln Asp Val Ser Leu Ala Leu Thr Gln Arg
1               5                   10                  15
</s400>
<s200>
<s210>82</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 82
Val Phe Ala Val Gly Val Arg
1               5
</s400>
<s200>
<s210>83</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 83
Asn Ile Asp Ser Glu Glu Val Gly Lys
1               5
</s400>
<s200>
<s210>84</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 84
Ile Ala Ser Asn Ser Ala Thr Ala Phe Arg
1               5                   10
</s400>
<s200>
<s210>85</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 85
Ala Cys Asn Leu Asp Val Ile Leu Ser Phe Asp Gly Ser Arg
1               5                   10
</s400>
<s200>
<s210>86</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 86
Asp Gln Asn Val Phe Val Ala Gln Lys
1               5
</s400>
<s200>
<s210>87</s210>
<s211>27</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 87
Val Ser Val Val Ala Asn Thr Pro Ser Gly Pro Val Glu Ala Phe Asp
1               5                   10                  15
Phe Asp Glu Tyr Gln Pro Glu Met Leu Glu Lys
            20                  25
</s400>
<s200>
<s210>88</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 88
Ser Gln His Pro Tyr Val Leu Thr Glu Asp Thr Leu Lys
1               5                   10
</s400>
<s200>
<s210>89</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 89
Val Val Ile His Phe Thr Asp Gly Ala Asp Gly Asp Leu Ala Asp Leu
1               5                   10                  15
His Arg
</s400>
<s200>
<s210>90</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 90
Ala Leu Ile Leu Val Gly Leu Glu Arg
1               5
</s400>
<s200>
<s210>91</s210>
<s211>6</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 91
Val Val Asn Leu Glu Arg
1               5
</s400>
<s200>
<s210>92</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 92
Leu Asn Leu Leu Asp Leu Asp Tyr Glu Leu Ala Glu Gln Leu Asp Asn
1               5                   10                  15
Ile Ala Glu Lys
            20
</s400>
<s200>
<s210>93</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 93
Gly Glu Thr Gly Asp Asp Gly Arg Asp Gly Val Gly Ser Glu Gly Arg
1               5                   10                  15
</s400>
<s200>
<s210>94</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 94
Gly Asp Ser Ile Asp Gln Cys Ala Leu Ile Gln Ser Ile Lys
1               5                   10
</s400>
<s200>
<s210>95</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 95
Asp Val Val Leu Ser Ile Val Asn Asp Leu Thr Ile Ala Glu Ser Asn
1               5                   10                  15
Cys Pro Arg
</s400>
<s200>
<s210>96</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 96
Val Ala Val Val Thr Tyr Asn Asn Glu Val Thr Thr Glu Ile Arg
1               5                   10                  15
</s400>
<s200>
<s210>97</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 97
Asn Leu Gln Val Ala Leu Thr Ser Lys
1               5
</s400>
<s200>
<s210>98</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 98
Val Ala Val Phe Phe Ser Asn Thr Pro Thr Arg
1               5                   10
</s400>
<s200>
<s210>99</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 99
Ala Leu Gly Ser Ala Ile Glu Tyr Thr Ile Glu Asn Val Phe Glu Ser
1               5                   10                  15
Ala Pro Asn Pro Arg
            20
</s400>
<s200>
<s210>100</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 100
Leu Leu Asp Ser Phe Val Ser Ser Glu Asn Ala Phe Tyr Leu Ser Pro
1               5                   10                  15
Asp Ile Arg
</s400>
<s200>
<s210>101</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 101
Leu Ile Gly Gln Ile Val Ser Ser Ile Thr Ala Ser Leu Arg
1               5                   10
</s400>
<s200>
<s210>102</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 102
Thr Ile Gln Phe Val Asp Trp Cys Pro Thr Gly Phe Lys
1               5                   10
</s400>
<s200>
<s210>103</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 103
Leu Ile Ser Gln Ile Val Ser Ser Ile Thr Ala Ser Leu Arg
1               5                   10
</s400>
<s200>
<s210>104</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 104
Thr Ile Gly Gly Gly Asp Asp Ser Phe Asn Thr Phe Phe Ser Glu Thr
1               5                   10                  15
Gly Ala Gly Lys
            20
</s400>
<s200>
<s210>105</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 105
Ala Val Phe Val Asp Leu Glu Pro Thr Val Ile Asp Glu Val Arg
1               5                   10                  15
</s400>
<s200>
<s210>106</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 106
Glu Ile Ile Asp Leu Val Leu Asp Arg
1               5
</s400>
<s200>
<s210>107</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 107
Asn Leu Asp Ile Glu Arg Pro Thr Tyr Thr Asn Leu Asn Arg
1               5                   10
</s400>
<s200>
<s210>108</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 108
Phe Asp Gly Ala Leu Asn Val Asp Leu Thr Glu Phe Gln Thr Asn Leu
1               5                   10                  15
Val Pro Tyr Pro Arg
            20
</s400>
<s200>
<s210>109</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 109
Val Gly Ile Asn Tyr Gln Pro Pro Thr Val Val Pro Gly Gly Asp Leu
1               5                   10                  15
Ala Lys
</s400>
<s200>
<s210>110</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 110
Asp Phe Ala Asp Ile Pro Asn Leu Arg
1               5
</s400>
<s200>
<s210>111</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 111
Arg Leu Asp Phe Thr Gly Asn Leu Ile Glu Asp Ile Glu Asp Gly Thr
1               5                   10                  15
Phe Ser Lys
</s400>
<s200>
<s210>112</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 112
Leu Ser Leu Leu Glu Glu Leu Ser Leu Ala Glu Asn Gln Leu Leu Lys
1               5                   10                  15
</s400>
<s200>
<s210>113</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 113
Leu Pro Val Leu Pro Pro Lys
1               5
</s400>
<s200>
<s210>114</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 114
Leu Ile His Leu Gln Phe Asn Asn Ile Ala Ser Ile Thr Asp Asp Thr
1               5                   10                  15
Phe Cys Lys
</s400>
<s200>
<s210>115</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 115
Asp Arg Ile Glu Glu Ile Arg
1               5
</s400>
<s200>
<s210>116</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 116
Leu Glu Gly Asn Pro Ile Val Leu Gly Lys
1               5                   10
</s400>
<s200>
<s210>117</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 117
Asp Ile Ala Pro Thr Leu Thr Leu Tyr Val Gly Lys
1               5                   10
</s400>
<s200>
<s210>118</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 118
Asn Pro Ala Asn Pro Val Gln Arg
1               5
</s400>
<s200>
<s210>119</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 119
Val Thr Ser Ile Gln Asp Trp Val Gln Lys
1               5                   10
</s400>
<s200>
<s210>120</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 120
Leu Asp Ile Asp Ser Pro Pro Ile Thr Ala Arg
1               5                   10
</s400>
<s200>
<s210>121</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 121
Asn Thr Gly Ile Ile Cys Thr Ile Gly Pro Ala Ser Arg
1               5                   10
</s400>
<s200>
<s210>122</s210>
<s211>23</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 122
Thr Ala Thr Glu Ser Phe Ala Ser Asp Pro Ile Leu Tyr Arg Pro Val
1               5                   10                  15
Ala Val Ala Leu Asp Thr Lys
            20
</s400>
<s200>
<s210>123</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 123
Leu Ala Pro Ile Thr Ser Asp Pro Thr Glu Ala Thr Ala Val Gly Ala
1               5                   10                  15
Val Glu Ala Ser Phe Lys
            20
</s400>
<s200>
<s210>124</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 124
Ala Pro Ile Ile Ala Val Thr Arg
1               5
</s400>
<s200>
<s210>125</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 125
Gly Ile Phe Pro Val Leu Cys Lys Asp Pro Val Gln Glu Ala Trp Ala
1               5                   10                  15
Glu Asp Val Asp Leu Arg
            20
</s400>
<s200>
<s210>126</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 126
Ala Ala Val Pro Ser Gly Ala Ser Thr Gly Ile Tyr Glu Ala Leu Glu
1               5                   10                  15
Leu Arg
</s400>
<s200>
<s210>127</s210>
<s211>26</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 127
Asp Ala Thr Asn Val Gly Asp Glu Gly Gly Phe Ala Pro Asn Ile Leu
1               5                   10                  15
Glu Asn Lys Glu Gly Leu Glu Leu Leu Lys
            20                  25
</s400>
<s200>
<s210>128</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 128
Tyr Ile Ser Pro Asp Gln Leu Ala Asp Leu Tyr Lys
1               5                   10
</s400>
<s200>
<s210>129</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 129
Ser Gly Glu Thr Glu Asp Thr Phe Ile Ala Asp Leu Val Val Gly Leu
1               5                   10                  15
Cys Thr Gly Gln Ile Lys
            20
</s400>
<s200>
<s210>130</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 130
Thr Ile Tyr Thr Pro Gly Ser Thr Val Leu Tyr Arg
1               5                   10
</s400>
<s200>
<s210>131</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 131
Ala Tyr Tyr Glu Asn Ser Pro Gln Gln Val Phe Ser Thr Glu Phe Glu
1               5                   10                  15
Val Lys
</s400>
<s200>
<s210>132</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 132
Glu Tyr Val Leu Pro Ser Phe Glu Val Ile Val Glu Pro Thr Glu Lys
1               5                   10                  15
</s400>
<s200>
<s210>133</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 133
Ile Pro Ile Glu Asp Gly Ser Gly Glu Val Val Leu Ser Arg
1               5                   10
</s400>
<s200>
<s210>134</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 134
Val Leu Leu Asp Gly Val Gln Asn Pro Arg
1               5                   10
</s400>
<s200>
<s210>135</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 135
Val Pro Val Ala Val Gln Gly Glu Asp Thr Val Gln Ser Leu Thr Gln
1               5                   10                  15
Gly Asp Gly Val Ala Lys
            20
</s400>
<s200>
<s210>136</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 136
Thr Lys Lys Gln Glu Leu Ser Glu Ala Glu Gln Ala Thr Arg
1               5                   10
</s400>
<s200>
<s210>137</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 137
Thr Glu Leu Arg Pro Gly Glu Thr Leu Asn Val Asn Phe Leu Leu Arg
1               5                   10                  15
</s400>
<s200>
<s210>138</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 138
Glu Pro Gly Gln Asp Leu Val Val Leu Pro Leu Ser Ile Thr Thr Asp
1               5                   10                  15
Phe Ile Pro Ser Phe Arg
            20
</s400>
<s200>
<s210>139</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 139
Leu Val Ala Tyr Tyr Thr Leu Ile Gly Ala Ser Gly Gln Arg
1               5                   10
</s400>
<s200>
<s210>140</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 140
Ile Trp Asp Val Val Glu Lys
1               5
</s400>
<s200>
<s210>141</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 141
Ala Ser His Leu Gly Leu Ala Arg
1               5
</s400>
<s200>
<s210>142</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 142
Ser Asn Leu Asp Glu Asp Ile Ile Ala Glu Glu Asn Ile Val Ser Arg
1               5                   10                  15
</s400>
<s200>
<s210>143</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 143
Leu Pro Tyr Ser Val Val Arg
1               5
</s400>
<s200>
<s210>144</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 144
Asn Glu Gln Val Glu Ile Arg
1               5
</s400>
<s200>
<s210>145</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 145
Ser Ser Leu Ser Val Pro Tyr Val Ile Val Pro Leu Lys
1               5                   10
</s400>
<s200>
<s210>146</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 146
Thr Gly Leu Gln Glu Val Glu Val Lys
1               5
</s400>
<s200>
<s210>147</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 147
Ile Leu Leu Asp Gly Thr Pro Val Ala Gln Met Thr Glu Asp Ala Val
1               5                   10                  15
Asp Ala Glu Arg
            20
</s400>
<s200>
<s210>148</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 148
Asp Phe Asp Phe Val Pro Pro Val Val Arg
1               5                   10
</s400>
<s200>
<s210>149</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 149
Val His Gln Tyr Phe Asn Val Glu Leu Ile Gln Pro Gly Ala Val Lys
1               5                   10                  15
</s400>
<s200>
<s210>150</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 150
Ala Cys Glu Pro Gly Val Asp Tyr Val Tyr Lys
1               5                   10
</s400>
<s200>
<s210>151</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 151
Val Gln Leu Ser Asn Asp Phe Asp Glu Tyr Ile Met Ala Ile Glu Gln
1               5                   10                  15
Thr Ile Lys
</s400>
<s200>
<s210>152</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 152
Ser Gly Ser Asp Glu Val Gln Val Gly Gln Gln Arg
1               5                   10
</s400>
<s200>
<s210>153</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 153
Asp Thr Trp Val Glu His Trp Pro Glu Glu Asp Glu Cys Gln Asp Glu
1               5                   10                  15
Glu Asn Gln Lys
            20
</s400>
<s200>
<s210>154</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 154
Asp Tyr Val Ser Gln Phe Glu Gly Ser Ala Leu Gly Lys
1               5                   10
</s400>
<s200>
<s210>155</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 155
Leu Leu Asp Asn Trp Asp Ser Val Thr Ser Thr Phe Ser Lys
1               5                   10
</s400>
<s200>
<s210>156</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 156
Gln Gly Leu Leu Pro Val Leu Glu Ser Phe Lys
1               5                   10
</s400>
<s200>
<s210>157</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 157
Val Ser Phe Leu Ser Ala Leu Glu Glu Tyr Thr Lys
1               5                   10
</s400>
<s200>
<s210>158</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 158
Ser Val Thr Glu Gln Gly Ala Glu Leu Ser Asn Glu Glu Arg
1               5                   10
</s400>
<s200>
<s210>159</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 159
Asp Ile Cys Asn Asp Val Leu Ser Leu Leu Glu Lys
1               5                   10
</s400>
<s200>
<s210>160</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 160
Tyr Leu Ala Glu Val Ala Ala Gly Asp Asp Lys Lys
1               5                   10
</s400>
<s200>
<s210>161</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 161
Thr Ala Phe Asp Glu Ala Ile Ala Glu Leu Asp Thr Leu Ser Glu Glu
1               5                   10                  15
Ser Tyr Lys
</s400>
<s200>
<s210>162</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 162
Val Val Gln Cys Ser Asp Leu Gly Leu Lys
1               5                   10
</s400>
<s200>
<s210>163</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 163
Glu Ile Ser Pro Asp Thr Thr Leu Leu Asp Leu Gln Asn Asn Asp Ile
1               5                   10                  15
Ser Glu Leu Arg
            20
</s400>
<s200>
<s210>164</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 164
Asn His Leu Val Glu Ile Pro Pro Asn Leu Pro Ser Ser Leu Val Glu
1               5                   10                  15
Leu Arg
</s400>
<s200>
<s210>165</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 165
Gly Val Phe Ser Gly Leu Arg
1               5
</s400>
<s200>
<s210>166</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 166
Asp Leu Pro Glu Thr Leu Asn Glu Leu His Leu Asp His Asn Lys
1               5                   10                  15
</s400>
<s200>
<s210>167</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 167
Ile Gln Ala Ile Glu Leu Glu Asp Leu Leu Arg
1               5                   10
</s400>
<s200>
<s210>168</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 168
Leu Gly Leu Gly His Asn Gln Ile Arg
1               5
</s400>
<s200>
<s210>169</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 169
Val Pro Ser Gly Leu Pro Asp Leu Lys
1               5
</s400>
<s200>
<s210>170</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 170
Asp Phe Glu Pro Ser Leu Gly Pro Val Cys Pro Phe Arg
1               5                   10
</s400>
<s200>
<s210>171</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 171
Val Val Gln Cys Ser Asp Leu Gly Leu Asp Lys Val Pro Lys
1               5                   10
</s400>
<s200>
<s210>172</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 172
Asp Leu Pro Pro Thr Thr Leu Leu Asp Leu Gln Asn Asn Lys
1               5                   10
</s400>
<s200>
<s210>173</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 173
Ile Thr Glu Ile Lys Asp Gly Asp Phe Lys
1               5                   10
</s400>
<s200>
<s210>174</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 174
Asn Leu His Ala Leu Ile Leu Val Asn Asn Lys
1               5                   10
</s400>
<s200>
<s210>175</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 175
Val Ser Pro Gly Ala Phe Thr Pro Leu Val Lys
1               5                   10
</s400>
<s200>
<s210>176</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 176
Val Pro Gly Gly Leu Ala Glu His Lys
1               5
</s400>
<s200>
<s210>177</s210>
<s211>24</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 177
Ala Ser Tyr Ser Gly Val Ser Leu Phe Ser Asn Pro Val Gln Tyr Trp
1               5                   10                  15
Glu Ile Gln Pro Ser Thr Phe Arg
            20
</s400>
<s200>
<s210>178</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 178
Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser Glu Glu Leu Gln
1               5                   10                  15
Ala Asn Lys
</s400>
<s200>
<s210>179</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 179
Ala Gly Val Glu Thr Thr Thr Pro Ser Lys
1               5                   10
</s400>
<s200>
<s210>180</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 180
Ala Thr Leu Val Cys Leu Ile Ser Asp Phe Tyr Pro Gly Ala Val Thr
1               5                   10                  15
Val Ala Trp Lys
            20
</s400>
<s200>
<s210>181</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 181
Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
1               5                   10                  15
</s400>
<s200>
<s210>182</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 182
Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val Glu Lys
1               5                   10                  15
</s400>
<s200>
<s210>183</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 183
Leu Asn Met Gly Ile Thr Asp Leu Gln Gly Leu Arg
1               5                   10
</s400>
<s200>
<s210>184</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 184
Val Gly Asp Thr Leu Asn Leu Asn Leu Arg
1               5                   10
</s400>
<s200>
<s210>185</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 185
Ser Phe Phe Pro Glu Asn Trp Leu Trp Arg
1               5                   10
</s400>
<s200>
<s210>186</s210>
<s211>26</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 186
Val Thr Ala Ser Asp Pro Leu Asp Thr Leu Gly Ser Glu Gly Ala Leu
1               5                   10                  15
Ser Pro Gly Gly Val Ala Ser Leu Leu Arg
            20                  25
</s400>
<s200>
<s210>187</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 187
Val Leu Ser Leu Ala Gln Glu Gln Val Gly Gly Ser Pro Glu Lys
1               5                   10                  15
</s400>
<s200>
<s210>188</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 188
Asp Ala Ser Gly Val Thr Phe Thr Trp Thr Pro Ser Ser Gly Lys
1               5                   10                  15
</s400>
<s200>
<s210>189</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 189
Ser Ala Val Gln Gly Pro Pro Glu Arg
1               5
</s400>
<s200>
<s210>190</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 190
Thr Phe Thr Cys Thr Ala Ala Tyr Pro Glu Ser Lys
1               5                   10
</s400>
<s200>
<s210>191</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 191
Thr Pro Leu Thr Ala Thr Leu Ser Lys
1               5
</s400>
<s200>
<s210>192</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 192
Trp Leu Gln Gly Ser Gln Glu Leu Pro Arg
1               5                   10
</s400>
<s200>
<s210>193</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 193
Tyr Leu Thr Trp Ala Ser Arg
1               5
</s400>
<s200>
<s210>194</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 194
Gln Glu Pro Ser Gln Gly Thr Thr Thr Phe Ala Val Thr Ser Ile Leu
1               5                   10                  15
Arg
</s400>
<s200>
<s210>195</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 195
Val Val Leu Ala Tyr Glu Pro Val Trp Ala Ile Gly Thr Gly Lys
1               5                   10                  15
</s400>
<s200>
<s210>196</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 196
Ser Asn Val Ser Asp Ala Val Ala Gln Ser Thr Arg
1               5                   10
</s400>
<s200>
<s210>197</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 197
Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys
1               5                   10
</s400>
<s200>
<s210>198</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 198
Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys
1               5                   10
</s400>
<s200>
<s210>199</s210>
<s211>26</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 199
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro
1               5                   10                  15
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
20                  25
</s400>
<s200>
<s210>200</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 200
Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro
1               5                   10                  15
Glu Val Lys
</s400>
<s200>
<s210>201</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 201
Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys
1               5                   10
</s400>
<s200>
<s210>202</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 202
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
1               5                   10                  15
Lys
</s400>
<s200>
<s210>203</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 203
Ser Thr Ser Glu Ser Thr Ala Ala Leu Gly Cys Leu Val Lys
1               5                   10
</s400>
<s200>
<s210>204</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 204
Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln
1               5                   10                  15
Pro Glu Asn Asn Tyr Lys
            20
</s400>
<s200>
<s210>205</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 205
Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro
1               5                   10                  15
Glu Val Gln Phe Lys
            20
</s400>
<s200>
<s210>206</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 206
Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys
1               5                   10
</s400>
<s200>
<s210>207</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 207
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
1               5                   10                  15
</s400>
<s200>
<s210>208</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 208
Asp Thr Leu Met Ile Ser Arg
1               5
</s400>
<s200>
<s210>209</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 209
Gly Pro Ser Val Phe Pro Leu Ala Pro Cys Ser Arg
1               5                   10
</s400>
<s200>
<s210>210</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 210
Asn Gln Cys Ser Leu Thr Cys Leu Val Lys
1               5                   10
</s400>
<s200>
<s210>211</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 211
Ser Leu Tyr Ala Ser Ser Pro Gly Gly Val Tyr Ala Thr Arg
1               5                   10
</s400>
<s200>
<s210>212</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 212
Leu Leu Gln Asp Ser Val Asp Phe Ser Leu Ala Asp Ala Ile Asn Thr
1               5                   10                  15
Glu Phe Lys
</s400>
<s200>
<s210>213</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 213
Val Glu Leu Gln Glu Leu Asn Asp Arg
1               5
</s400>
<s200>
<s210>214</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 214
Ile Leu Leu Ala Glu Leu Glu Gln Leu Lys
1               5                   10
</s400>
<s200>
<s210>215</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 215
Glu Glu Ala Glu Asn Thr Leu Gln Ser Phe Arg
1               5                   10
</s400>
<s200>
<s210>216</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 216
Gln Asp Val Asp Asn Ala Ser Leu Ala Arg
1               5                   10
</s400>
<s200>
<s210>217</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 217
Asn Leu Gln Glu Ala Glu Glu Trp Tyr Lys
1               5                   10
</s400>
<s200>
<s210>218</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 218
Phe Ala Asp Leu Ser Glu Ala Ala Asn Arg
1               5                   10
</s400>
<s200>
<s210>219</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 219
Gln Val Gln Ser Leu Thr Cys Glu Val Asp Ala Leu Lys
1               5                   10
</s400>
<s200>
<s210>220</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 220
Ile Ser Leu Pro Leu Pro Asn Phe Ser Ser Leu Asn Leu Arg
1               5                   10
</s400>
<s200>
<s210>221</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 221
Tyr Ser Leu Glu Pro Val Ala Val Glu Leu Lys
1               5                   10
</s400>
<s200>
<s210>222</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 222
Ala Cys Ala Asn Pro Ala Ala Gly Ser Val Ile Leu Leu Glu Asn Leu
1               5                   10                  15
Arg
</s400>
<s200>
<s210>223</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 223
Gln Ile Val Trp Asn Gly Pro Val Gly Val Phe Glu Trp Glu Ala Phe
1               5                   10                  15
Ala Arg
</s400>
<s200>
<s210>224</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 224
Thr Asn Gln Leu Asn Leu Gln Asn Thr Ala Thr Lys
1               5                   10
</s400>
<s200>
<s210>225</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 225
His Phe Leu Glu Asn Leu Val Thr Ala Phe Asp Val Gly Ser Glu Lys
1               5                   10                  15
</s400>
<s200>
<s210>226</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 226
Asp Glu Val Ile Glu Ala Val Arg
1               5
</s400>
<s200>
<s210>227</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 227
Ile Gly Ile Leu Ile Thr Asp Gly Lys
1               5
</s400>
<s200>
<s210>228</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 228
Ser Gln Asp Asp Ile Ile Pro Pro Ser Arg
1               5                   10
</s400>
<s200>
<s210>229</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 229
Ala Ser Ala His Ala Ile Thr Gly Pro Pro Thr Glu Leu Ile Thr Ser
1               5                   10                  15
Glu Val Thr Ala Arg
            20
</s400>
<s200>
<s210>230</s210>
<s211>26</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 230
Trp Asp Ala Val Thr Gly Ala Ser Gly Tyr Leu Ile Leu Tyr Ala Pro
1               5                   10                  15
Leu Thr Glu Gly Leu Ala Gly Asp Glu Lys
            20                  25
</s400>
<s200>
<s210>231</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 231
Ile Ser Asn Val Gly Ser Asn Ser Ala Arg
1               5                   10
</s400>
<s200>
<s210>232</s210>
<s211>25</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 232
Ile Val Tyr Asn Asn Ala Asp Gly Thr Glu Ile Asn Glu Val Glu Val
1               5                   10                  15
Asp Pro Ile Thr Thr Phe Pro Leu Lys
            20                  25
</s400>
<s200>
<s210>233</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 233
Asn Leu Val Val Gly Asp Glu Thr Thr Ser Ser Leu Arg
1               5                   10
</s400>
<s200>
<s210>234</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 234
Trp Asp Ile Ser Asp Ser Asp Val Gln Gln Phe Arg
1               5                   10
</s400>
<s200>
<s210>235</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 235
Val Thr Val Thr Pro Ile Tyr Thr Asp Gly Glu Gly Val Ser Val Ser
1               5                   10                  15
Ala Pro Gly Lys
            20
</s400>
<s200>
<s210>236</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 236
Thr Leu Pro Ser Ser Gly Pro Gln Asn Leu Arg
1               5                   10
</s400>
<s200>
<s210>237</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 237
Val Ser Glu Glu Trp Tyr Asn Arg
1               5
</s400>
<s200>
<s210>238</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 238
Ile Thr Trp Asp Pro Pro Ser Ser Pro Val Lys
1               5                   10
</s400>
<s200>
<s210>239</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 239
Thr Leu Phe Leu Gly Val Thr Asn Leu Gln Ala Lys
1               5                   10
</s400>
<s200>
<s210>240</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 240
Val Val Ile Glu Ser Leu Gln Asp Arg
1               5
</s400>
<s200>
<s210>241</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 241
Ile Ile Ser Phe Leu Tyr Ser Thr Val Gly Ala Leu Asn Lys
1               5                   10
</s400>
<s200>
<s210>242</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 242
Thr Lys Glu Thr Leu Leu Asp Ala Ile Lys
1               5                   10
</s400>
<s200>
<s210>243</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 243
Asp Thr Leu Phe Thr Ala Glu Ser Gly Thr Arg
1               5                   10
</s400>
<s200>
<s210>244</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 244
Val Ile Val Val Ile Thr Asp Gly Arg
1               5
</s400>
<s200>
<s210>245</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 245
His Val Phe Phe Val Asp Asp Phe Asp Ala Phe Lys
1               5                   10
</s400>
<s200>
<s210>246</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 246
Asp Gly Ile Asp Leu Ala Gly Phe Lys
1               5
</s400>
<s200>
<s210>247</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 247
Ile Leu Pro Asp Thr Pro Gln Glu Pro Phe Ala Leu Trp Glu Ile Leu
1               5                   10                  15
Asn Lys
</s400>
<s200>
<s210>248</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 248
Asn Ser Asp Pro Leu Val Gly Val Ile Leu Asp Asn Gly Gly Lys
1               5                   10                  15
</s400>
<s200>
<s210>249</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 249
Asp Leu Ala Asp Glu Leu Ala Leu Val Asp Val Ile Glu Asp Lys
1               5                   10                  15
</s400>
<s200>
<s210>250</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 250
Val Ile Gly Ser Gly Cys Asn Leu Asp Ser Ala Arg
1               5                   10
</s400>
<s200>
<s210>251</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 251
Asp Ala Glu Glu Ala Ile Ser Gln Thr Ile Asp Thr Ile Val Asp Ile
1               5                   10                  15
Lys
</s400>
<s200>
<s210>252</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 252
Arg Phe Ile Asp Asn Leu Arg
1               5
</s400>
<s200>
<s210>253</s210>
<s211>6</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 253
Phe Ile Asp Asn Leu Arg
1               5
</s400>
<s200>
<s210>254</s210>
<s211>29</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 254
Tyr Leu Ile Val Val Thr Asp Gly His Pro Leu Glu Gly Tyr Lys Glu
1               5                   10                  15
Pro Cys Gly Gly Leu Glu Asp Ala Val Asn Glu Ala Lys
            20                  25
</s400>
<s200>
<s210>255</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 255
Val Phe Ser Val Ala Ile Thr Pro Asp His Leu Glu Pro Arg
1               5                   10
</s400>
<s200>
<s210>256</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 256
Leu Ser Ile Ile Ala Thr Asp His Thr Tyr Arg
1               5                   10
</s400>
<s200>
<s210>257</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 257
Ser Gly Asp Glu Gly Pro Pro Gly Ser Glu Gly Ala Arg
1               5                   10
</s400>
<s200>
<s210>258</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 258
Ser Leu Gln Trp Met Ala Gly Gly Thr Phe Thr Gly Glu Ala Leu Gln
1               5                   10                  15
Tyr Thr Arg
</s400>
<s200>
<s210>259</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 259
Ile Ala Leu Val Ile Thr Asp Gly Arg
1               5
</s400>
<s200>
<s210>260</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 260
Asp Thr Thr Pro Leu Asn Val Leu Cys Ser Pro Gly Ile Gln Val Val
1               5                   10                  15
Ser Val Gly Ile Lys
            20
</s400>
<s200>
<s210>261</s210>
<s211>33</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 261
Asp Val Phe Asp Phe Ile Pro Gly Ser Asp Gln Leu Asn Val Ile Ser
1               5                   10                  15
Cys Gln Gly Leu Ala Pro Ser Gln Gly Arg Pro Gly Leu Ser Leu Val
            20                  25                  30
Lys
</s400>
<s200>
<s210>262</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 262
Glu Asn Tyr Ala Glu Leu Leu Glu Asp Ala Phe Leu Lys
1               5                   10
</s400>
<s200>
<s210>263</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 263
Leu Leu Leu Phe Ser Asp Gly Asn Ser Gln Gly Ala Thr Pro Ala Ala
1               5                   10                  15
Ile Glu Lys
</s400>
<s200>
<s210>264</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 264
Ala Gly Ile Glu Ile Phe Val Val Val Val Gly Arg
1               5                   10
</s400>
<s200>
<s210>265</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 265
Thr Ala Glu Tyr Asp Val Ala Tyr Gly Glu Ser His Leu Phe Arg
1               5                   10                  15
</s400>
<s200>
<s210>266</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 266
Val Pro Ser Tyr Gln Ala Leu Leu Arg
1               5
</s400>
<s200>
<s210>267</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 267
Gly Val Phe His Gln Thr Val Ser Arg
1               5
</s400>
<s200>
<s210>268</s210>
<s211>23</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 268
Ile Glu Asp Ala Asn Leu Ile Pro Pro Val Pro Asp Asp Lys Phe Gln
1               5                   10                  15
Asp Leu Val Asp Ala Val Arg
            20
</s400>
<s200>
<s210>269</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 269
Phe Val Phe Gly Thr Thr Pro Glu Asp Ile Leu Arg
1               5                   10
</s400>
<s200>
<s210>270</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 270
Thr Ile Val Thr Thr Leu Gln Asp Ser Ile Arg
1               5                   10
</s400>
<s200>
<s210>271</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 271
Lys Val Thr Glu Glu Asn Lys Glu Leu Ala Asn Glu Leu Arg
1               5                   10
</s400>
<s200>
<s210>272</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 272
Asp Val Trp Gly Ile Glu Gly Pro Ile Asp Ala Ala Phe Thr Arg
1               5                   10                  15
</s400>
<s200>
<s210>273</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 273
Phe Glu Asp Gly Val Leu Asp Pro Asp Tyr Pro Arg
1               5                   10
</s400>
<s200>
<s210>274</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 274
Asn Leu Gln Gly Ile Ser Ser Phe Arg
1               5
</s400>
<s200>
<s210>275</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 275
Leu Phe Ala Val Ala Pro Asn Gln Asn Leu Lys
1               5                   10
</s400>
<s200>
<s210>276</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 276
Asp Ile Ala Ser Thr Pro His Glu Leu Tyr Arg
1               5                   10
</s400>
<s200>
<s210>277</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 277
Asn Asp Tyr Ala Thr Met Leu Pro Asp Ser Thr Glu Ile Asp Gln Asp
1               5                   10                  15
Thr Ile Asn Arg
            20
</s400>
<s200>
<s210>278</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 278
Asn Phe Val Ile Asn Val Val Asn Arg
1               5
</s400>
<s200>
<s210>279</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 279
Asn Leu Glu Trp Ile Ala Gly Gly Thr Trp Thr Pro Ser Ala Leu Lys
1               5                   10                  15
</s400>
<s200>
<s210>280</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 280
Val Phe Ala Val Val Ile Thr Asp Gly Arg
1               5                   10
</s400>
<s200>
<s210>281</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 281
Asp Asp Asp Leu Asn Leu Arg
1               5
</s400>
<s200>
<s210>282</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 282
His Glu Ser Glu Asn Leu Tyr Ser Ile Ala Cys Asp Lys Pro Gln Gln
1               5                   10                  15
Val Arg
</s400>
<s200>
<s210>283</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 283
Leu Gly Glu Gln Asn Phe His Lys
1               5
</s400>
<s200>
<s210>284</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 284
Phe Val Glu Gln Val Ala Arg
1               5
</s400>
<s200>
<s210>285</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 285
Arg Asp Asp Asp Pro Leu Asn Ala Arg
1               5
</s400>
<s200>
<s210>286</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 286
Ala Ala Val Phe His Glu Lys Asp Tyr Asp Ser Leu Ala Gln Pro Gly
1               5                   10                  15
Phe Phe Asp Arg
            20
</s400>
<s200>
<s210>287</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 287
Asp Ala Gly Val Ile Ala Gly Leu Asn Val Leu Arg
1               5                   10
</s400>
<s200>
<s210>288</s210>
<s211>31</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 288
Glu Leu Glu Gln Val Cys Asn Pro Ile Ile Ser Gly Leu Tyr Gln Gly
1               5                   10                  15
Ala Gly Gly Pro Gly Pro Gly Gly Phe Gly Ala Gln Gly Pro Lys
            20                  25                  30
</s400>
<s200>
<s210>289</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 289
Val Ser Phe Glu Leu Phe Ala Asp Lys
1               5
</s400>
<s200>
<s210>290</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 290
Phe Glu Asp Glu Asn Phe Ile Leu Lys
1               5
</s400>
<s200>
<s210>291</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 291
Ser Val Leu Gly Gln Leu Gly Ile Thr Lys
1               5                   10
</s400>
<s200>
<s210>292</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 292
Val Phe Ser Asn Gly Ala Asp Leu Ser Gly Val Thr Glu Glu Ala Pro
1               5                   10                  15
Leu Lys
</s400>
<s200>
<s210>293</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 293
Ile Thr Pro Asn Leu Ala Glu Phe Ala Phe Ser Leu Tyr Arg
1               5                   10
</s400>
<s200>
<s210>294</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 294
Ala Val Leu Thr Ile Asp Glu Lys
1               5
</s400>
<s200>
<s210>295</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 295
Val Val Asn Pro Thr Gln Lys
1               5
</s400>
<s200>
<s210>296</s210>
<s211>24</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 296
Thr Leu Asn Gln Pro Asp Ser Gln Leu Gln Leu Thr Thr Gly Asn Gly
1               5                   10                  15
Leu Phe Leu Ser Glu Gly Leu Lys
            20
</s400>
<s200>
<s210>297</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 297
Leu Gln His Leu Glu Asn Glu Leu Thr His Asp Ile Ile Thr Lys
1               5                   10                  15
</s400>
<s200>
<s210>298</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 298
Ser Ala Ser Leu His Leu Pro Lys
1               5
</s400>
<s200>
<s210>299</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 299
Leu Ala Ala Leu Asn Pro Glu Ser Asn Thr Ala Gly Leu Asp Ile Phe
1               5                   10                  15
Ala Lys
</s400>
<s200>
<s210>300</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 300
Phe Leu Asp Gly Asn Glu Leu Thr Leu Ala Asp Cys Asn Leu Leu Pro
1               5                   10                  15
Lys
</s400>
<s200>
<s210>301</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 301
Gly Val Asp Glu Val Thr Ile Val Asn Ile Leu Thr Asn Arg
1               5                   10
</s400>
<s200>
<s210>302</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 302
Thr Pro Ala Gln Tyr Asp Ala Ser Glu Leu Lys
1               5                   10
</s400>
<s200>
<s210>303</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 303
Gly Leu Gly Thr Asp Glu Asp Ser Leu Ile Glu Ile Ile Cys Ser Arg
1               5                   10                  15
</s400>
<s200>
<s210>304</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 304
Thr Asn Gln Glu Leu Gln Glu Ile Asn Arg
1               5                   10
</s400>
<s200>
<s210>305</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 305
Thr Asp Leu Glu Lys Asp Ile Ile Ser Asp Thr Ser Gly Asp Phe Arg
1               5                   10                  15
Lys
</s400>
<s200>
<s210>306</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 306
Gly Leu Gly Thr Asp Glu Glu Ser Ile Leu Thr Leu Leu Thr Ser Arg
1               5                   10                  15
</s400>
<s200>
<s210>307</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human breast carcinomas</s223>
</s220>
</s200>
<s400> 307
Asp Leu Leu Asp Asp Leu Lys Ser Glu Leu Thr Gly Lys
1               5                   10
</s400>
<s200>
<s210>308</s210>
<s211>21</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 308
cccttcaccc agttggacct g                                               21
</s400>
<s200>
<s210>309</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 309
gtgattccca tcctggtcat                                                 20
</s400>
<s200>
<s210>310</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 310
tgctggagac tgtggtatgc                                                 20
</s400>
<s200>
<s210>311</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 311
agcaagagtg ccctgaatgt                                                 20
</s400>
<s200>
<s210>312</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 312
gcgtgatggt gtgctgttcc                                                 20
</s400>
<s200>
<s210>313</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 313
cgagggcatc tacttcaagc                                                 20
</s400>
<s200>
<s210>314</s210>
<s211>21</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 314
gcgacagaca gaaggcaaac c                                               21
</s400>
<s200>
<s210>315</s210>
<s211>21</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 315
aaggtctacc aagggcatac g                                               21
</s400>
<s200>
<s210>316</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 316
aggtgacgtg gtggacattt                                                 20
</s400>
<s200>
<s210>317</s210>
<s211>21</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 317
tgcactcgta cctgactgac a                                               21
</s400>
<s200>
<s210>318</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 318
ccctggaagt tgtcctctca                                                 20
</s400>
<s200>
<s210>319</s210>
<s211>19</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 319
agcctgaaag cagctccat                                                  19
</s400>
<s200>
<s210>320</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 320
ctctggtgtc cgtgctggtg                                                 20
</s400>
<s200>
<s210>321</s210>
<s211>21</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 321
gagtgagtct gtggaggatg g                                               21
</s400>
<s200>
<s210>322</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 322
aagcaggtga cggtgtgtgg                                                 20
</s400>
<s200>
<s210>323</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 323
gcccagcttc ttctccatct                                                 20
</s400>
<s200>
<s210>324</s210>
<s211>21</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 324
aacagaagca gccttccacc c                                               21
</s400>
<s200>
<s210>325</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 325
ggtcgagctt cccattgtag                                                 20
</s400>
<s200>
<s210>326</s210>
<s211>21</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 326
gacagcccta tgccgtcagt g                                               21
</s400>
<s200>
<s210>327</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 327
agaaggctgc tgttggtgtt                                                 20
</s400>
<s200>
<s210>328</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 328
gcaccataga cctgggcgag                                                 20
</s400>
<s200>
<s210>329</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 329
taatgcagca gcttgtccag                                                 20
</s400>
<s200>
<s210>330</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 330
actcaatttg ggcactctgg                                                 20
</s400>
<s200>
<s210>331</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 331
tgccatagaa actgcgactg                                                 20
</s400>
<s200>
<s210>332</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 332
acagggactt ccgcatgtgg                                                 20
</s400>
<s200>
<s210>333</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 333
cgcttgtcct cgtagtcacc                                                 20
</s400>
<s200>
<s210>334</s210>
<s211>21</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 334
ccgacagaga cgagtgtagg c                                               21
</s400>
<s200>
<s210>335</s210>
<s211>21</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 335
tatcggtgtg atagcccaga a                                               21
</s400>
<s200>
<s210>336</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 336
gcttcaggct ctcttgctca                                                 20
</s400>
<s200>
<s210>337</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 337
gaccgagtcc tccttctcct                                                 20
</s400>
<s200>
<s210>338</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 338
tcctctgcca gtgccttaat                                                 20
</s400>
<s200>
<s210>339</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 339
gccagtgcct tgatgtacct                                                 20
</s400>
<s200>
<s210>340</s210>
<s211>21</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 340
aataggcagg actggcgaac c                                               21
</s400>
<s200>
<s210>341</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 341
gaagatgtga gccagcacct                                                 20
</s400>
<s200>
<s210>342</s210>
<s211>21</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 342
tgcactcggt ccagcataag g                                               21
</s400>
<s200>
<s210>343</s210>
<s211>19</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 343
tgcagctctg gcttctgac                                                  19
</s400>
<s200>
<s210>344</s210>
<s211>21</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 344
cattctgcgt gcgagaagct g                                               21
</s400>
<s200>
<s210>345</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 345
gcgaggtctt ctggtacagc                                                 20
</s400>
<s200>
<s210>346</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 346
gccacagctc tgccagtacc                                                 20
</s400>
<s200>
<s210>347</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>artificial</s213>
<s220>
<s223>synthetic oligonucleotide primer</s223>
</s220>
</s200>
<s400> 347
tggtttcttg gtagctgctg                                                 20
</s400>
<s200>
<s210>348</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 348
Asn Gln Leu Thr Ser Asn Pro Glu Asn Thr Val Phe Asp Ala Lys
1               5                   10                  15
</s400>
<s200>
<s210>349</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 349
Thr Trp Asn Asp Pro Ser Val Gln Gln Asp Ile Lys
1               5                   10
</s400>
<s200>
<s210>350</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 350
Lys Ser Asp Ile Asp Glu Ile Val Leu Val Gly Gly Ser Thr Arg
1               5                   10                  15
</s400>
<s200>
<s210>351</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 351
Ser Gln Ile Phe Ser Thr Ala Ser Asp Asn Gln Pro Thr Val Thr Ile
1               5                   10                  15
Lys
</s400>
<s200>
<s210>352</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 352
Ile Thr Ile Thr Asn Asp Gln Asn Arg
1               5
</s400>
<s200>
<s210>353</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 353
Asn Glu Leu Glu Ser Tyr Ala Tyr Ser Leu Lys
1               5                   10
</s400>
<s200>
<s210>354</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 354
Glu Leu Glu Glu Ile Val Gln Pro Ile Ile Ser Lys
1               5                   10
</s400>
<s200>
<s210>355</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 355
Ile Ile Asn Glu Pro Thr Ala Ala Ala Ile Ala Tyr Gly Leu Asp Lys
1               5                   10                  15
</s400>
<s200>
<s210>356</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound fraction isolated from
      human ovarian tumors</s223>
</s220>
</s200>
<s400> 356
Ile Thr Gly Glu Ala Phe Val Gln Phe Ala Ser Gln Glu Leu Ala Glu
1               5                   10                  15
Lys
</s400>
<s200>
<s210>357</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 357
Ala Thr Glu Asn Asp Ile Tyr Asn Phe Phe Ser Pro Leu Asn Pro Val
1               5                   10                  15
Arg
</s400>
<s200>
<s210>358</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 358
Thr Val Glu Ser Ile Thr Asp Ile Arg
1               5
</s400>
<s200>
<s210>359</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 359
Phe Phe Leu Gln Gly Ile Gln Leu Asn Thr Ile Leu Pro Asp Ala Arg
1               5                   10                  15
</s400>
<s200>
<s210>360</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 360
Asn His Leu Val Glu Ile Pro Pro Asn Leu Pro Ser Ser Leu Val Glu
1               5                   10                  15
Leu Arg
</s400>
<s200>
<s210>361</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 361
Asp Leu Pro Glu Thr Leu Asn Glu Leu His Leu Asp His Asn Lys
1               5                   10                  15
</s400>
<s200>
<s210>362</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 362
Ile Gln Ala Ile Glu Leu Glu Asp Leu Leu Arg
1               5                   10
</s400>
<s200>
<s210>363</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 363
Leu Gly Leu Gly His Asn Gln Ile Arg
1               5
</s400>
<s200>
<s210>364</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 364
Val Pro Ser Gly Leu Pro Asp Leu Lys
1               5
</s400>
<s200>
<s210>365</s210>
<s211>24</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 365
Ala Tyr Tyr Asn Gly Ile Ser Leu Phe Asn Asn Pro Val Pro Tyr Trp
1               5                   10                  15
Glu Val Gln Pro Ala Thr Phe Arg
20
</s400>
<s200>
<s210>366</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 366
Leu Ala Ile Gln Phe Gly Asn Tyr Lys
1               5
</s400>
<s200>
<s210>367</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 367
Ala Leu Tyr Leu Gln Tyr Thr Asp Glu Thr Phe Arg
1               5                   10
</s400>
<s200>
<s210>368</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 368
Gly Ala Tyr Pro Leu Ser Ile Glu Pro Ile Gly Val Arg
1               5                   10
</s400>
<s200>
<s210>369</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 369
Asn Asn Glu Gly Thr Tyr Tyr Ser Pro Asn Tyr Asn Pro Gln Ser Arg
1               5                   10                  15
</s400>
<s200>
<s210>370</s210>
<s211>26</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 370
Asp Val Asp Lys Glu Phe Tyr Leu Phe Pro Thr Val Phe Asp Glu Asn
1               5                   10                  15
Glu Ser Leu Leu Leu Glu Asp Asn Ile Arg
            20                  25
</s400>
<s200>
<s210>371</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 371
Lys Ala Glu Glu Glu His Leu Gly Ile Leu Gly Pro Gln Leu His Ala
1               5                   10                  15
Asp Val Gly Asp Lys
            20
</s400>
<s200>
<s210>372</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 372
Val Asn Lys Asp Asp Glu Glu Phe Ile Glu Ser Asn Lys
1               5                   10
</s400>
<s200>
<s210>373</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 373
Val Asp Ala Thr Glu Glu Ser Asp Leu Ala Gln Gln Tyr Gly Val Arg
1               5                   10                  15
</s400>
<s200>
<s210>374</s210>
<s211>30</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 374
Thr Gly Pro Ala Ala Thr Thr Leu Pro Asp Gly Ala Ala Ala Glu Ser
1               5                   10                  15
Leu Val Glu Ser Ser Glu Val Ala Val Ile Gly Phe Phe Lys
            20                  25                  30
</s400>
<s200>
<s210>375</s210>
<s211>25</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 375
Gln Phe Leu Gln Ala Ala Glu Ala Ile Asp Asp Ile Pro Phe Gly Ile
1               5                   10                  15
Thr Ser Asn Ser Asp Val Phe Ser Lys
            20                  25
</s400>
<s200>
<s210>376</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 376
Tyr Gln Leu Asp Lys Asp Gly Val Val Leu Phe Lys
1               5                   10
</s400>
<s200>
<s210>377</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 377
Thr His Ile Leu Leu Phe Leu Pro Lys
1               5
</s400>
<s200>
<s210>378</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 378
Ile Leu Glu Phe Phe Gly Leu Lys
1               5
</s400>
<s200>
<s210>379</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 379
Asn Phe Glu Asp Val Ala Phe Asp Glu Lys Lys
1               5                   10
</s400>
<s200>
<s210>380</s210>
<s211>23</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 380
Val Ile Ser Thr Ile Thr Asn Asn Ile Gln Gln Ile Ile Glu Ile Glu
1               5                   10                  15
Asp Thr Phe Glu Thr Leu Arg
20
</s400>
<s200>
<s210>381</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 381
Ile Leu Gly Asp Pro Glu Ala Leu Arg
1               5
</s400>
<s200>
<s210>382</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 382
Asp Ile Leu Ala Thr Asn Gly Val Ile His Tyr Ile Asp Glu Leu Leu
1               5                   10                  15
Ile Pro Asp Ser Ala Lys
            20
</s400>
<s200>
<s210>383</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 383
Thr Leu Phe Glu Leu Ala Ala Glu Ser Asp Val Ser Thr Ala Ile Asp
1               5                   10                  15
Leu Phe Arg
</s400>
<s200>
<s210>384</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 384
Leu Thr Leu Leu Ala Pro Leu Asn Ser Val Phe Lys
1               5                   10
</s400>
<s200>
<s210>385</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 385
Glu Gly Val Tyr Thr Val Phe Ala Pro Thr Asn Glu Ala Phe Arg
1               5                   10                  15
</s400>
<s200>
<s210>386</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 386
Ser Leu Gln Gly Asp Lys Leu Glu Val Ser Leu Lys
1               5                   10
</s400>
<s200>
<s210>387</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 387
Asn Phe Ile Asn Asn Pro Leu Ala Gln Ala Asp Trp Ala Ala Lys
1               5                   10                  15
</s400>
<s200>
<s210>388</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 388
Val Ile Ser Gly Val Leu Gln Leu Gly Asn Ile Val Phe Lys
1               5                   10
</s400>
<s200>
<s210>389</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 389
Val Val Phe Gln Glu Phe Arg
1               5
</s400>
<s200>
<s210>390</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 390
Ala Leu Glu Leu Asp Ser Asn Leu Tyr Arg
1               5                   10
</s400>
<s200>
<s210>391</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 391
Ile Ala Glu Phe Thr Thr Asn Leu Thr Glu Glu Glu Glu Lys
1               5                   10
</s400>
<s200>
<s210>392</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 392
Ile Arg Glu Leu Glu Ser Gln Ile Ser Glu Leu Gln Glu Asp Leu Glu
1               5                   10                  15
Ser Glu Arg
</s400>
<s200>
<s210>393</s210>
<s211>27</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 393
Asp Leu Gly Glu Glu Leu Glu Ala Leu Lys Thr Glu Leu Glu Asp Thr
1               5                   10                  15
Leu Asp Ser Thr Ala Ala Gln Gln Glu Leu Arg
            20                  25
</s400>
<s200>
<s210>394</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 394
Asp Phe Ser Ala Leu Glu Ser Gln Leu Gln Asp Thr Gln Glu Leu Leu
1               5                   10                  15
Gln Glu Glu Asn Arg
            20
</s400>
<s200>
<s210>395</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 395
Asp Leu Glu Gly Leu Ser Gln Arg
1               5
</s400>
<s200>
<s210>396</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 396
Leu Gln Gln Glu Leu Asp Asp Leu Leu Val Asp Leu Asp His Gln Arg
1               5                   10                  15
</s400>
<s200>
<s210>397</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 397
Gln Ala Gln Gln Glu Arg Asp Glu Leu Ala Asp Glu Ile Ala Asn Ser
1               5                   10                  15
Ser Gly Lys
</s400>
<s200>
<s210>398</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 398
Ile Ala Gln Leu Glu Glu Glu Leu Glu Glu Glu Gln Gly Asn Thr Glu
1               5                   10                  15
Leu Ile Asn Asp Arg
            20
</s400>
<s200>
<s210>399</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 399
Ala Asn Leu Gln Ile Asp Gln Ile Asn Thr Asp Leu Asn Leu Glu Arg
1               5                   10                  15
</s400>
<s200>
<s210>400</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 400
Ile Ala Gln Leu Glu Glu Gln Leu Asp Asn Glu Thr Lys
1               5                   10
</s400>
<s200>
<s210>401</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 401
Gln Leu Glu Glu Ala Glu Glu Glu Ala Gln Arg
1               5                   10
</s400>
<s200>
<s210>402</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 402
Gln Leu Leu Gln Ala Asn Pro Ile Leu Glu Ala Phe Gly Asn Ala Lys
1               5                   10                  15
</s400>
<s200>
<s210>403</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 403
Lys Glu Glu Glu Leu Gln Ala Ala Leu Ala Arg
1               5                   10
</s400>
<s200>
<s210>404</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 404
Lys Phe Asp Gln Leu Leu Ala Glu Glu Lys
1               5                   10
</s400>
<s200>
<s210>405</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 405
Thr Gln Leu Glu Glu Leu Glu Asp Glu Leu Gln Ala Thr Glu Asp Ala
1               5                   10                  15
Lys
</s400>
<s200>
<s210>406</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 406
Tyr Gly Leu Val Thr Tyr Ala Thr Tyr Pro Lys
1               5                   10
</s400>
<s200>
<s210>407</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 407
Val Ser Glu Ala Asp Ser Ser Asn Ala Asp Trp Val Thr Lys
1               5                   10
</s400>
<s200>
<s210>408</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 408
Glu Ala Gly Ile Pro Glu Phe Tyr Asp Tyr Asp Val Ala Leu Ile Lys
1               5                   10                  15
</s400>
<s200>
<s210>409</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 409
Asn Phe Ile Asn Ser Pro Val Ala Gln Ala Asp Trp Ala Ala Lys
1               5                   10                  15
</s400>
<s200>
<s210>410</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 410
Val Val Ser Ser Val Leu Gln Leu Gly Asn Ile Val Phe Lys
1               5                   10
</s400>
<s200>
<s210>411</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 411
Val Asp Tyr Asn Ala Ser Ala Trp Leu Thr Lys
1               5                   10
</s400>
<s200>
<s210>412</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 412
His Ala Gln Ala Val Glu Glu Leu Thr Glu Gln Leu Glu Gln Phe Lys
1               5                   10                  15
Arg
</s400>
<s200>
<s210>413</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 413
Asp Val Ala Ser Leu Ser Ser Gln Leu Gln Asp Thr Gln Glu Leu Leu
1               5                   10                  15
Gln Glu Glu Thr Arg
20
</s400>
<s200>
<s210>414</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 414
Leu Gln Asp Phe Ala Ser Thr Val Glu Ala Leu Glu Glu Gly Lys
1               5                   10                  15
</s400>
<s200>
<s210>415</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 415
Glu Ile Glu Asn Leu Thr Gln Gln Tyr Glu Glu Lys
1               5                   10
</s400>
<s200>
<s210>416</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 416
Leu Gln Gln Glu Leu Asp Asp Leu Val Val Asp Leu Asp Asn Gln Arg
1               5                   10                  15
</s400>
<s200>
<s210>417</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 417
Lys Ala Thr Gln Gln Ala Glu Gln Leu Ser Asn Glu Leu Ala Thr Glu
1               5                   10                  15
Arg
</s400>
<s200>
<s210>418</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 418
Ile Ala Gln Leu Glu Glu Gln Val Glu Gln Glu Ala Arg
1               5                   10
</s400>
<s200>
<s210>419</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 419
Gln Leu Leu Gln Ala Asn Pro Ile Leu Glu Ala Phe Gly Asn Ala Lys
1               5                   10                  15
</s400>
<s200>
<s210>420</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 420
Lys Glu Glu Glu Leu Gln Ala Ala Leu Ala Arg
1               5                   10
</s400>
<s200>
<s210>421</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 421
Lys Phe Asp Gln Leu Leu Ala Glu Glu Lys
1               5                   10
</s400>
<s200>
<s210>422</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 422
Thr Gln Leu Glu Glu Leu Glu Asp Glu Leu Gln Ala Thr Glu Asp Ala
1               5                   10                  15
Lys
</s400>
<s200>
<s210>423</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 423
Thr Gln Leu Glu Glu Leu Glu Asp Glu Leu Gln Ala Thr Glu Asp Ala
1               5                   10                  15
Lys
</s400>
<s200>
<s210>424</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 424
Phe Tyr Gly Asp Glu Glu Lys Asp Lys
1               5
</s400>
<s200>
<s210>425</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 425
Gly Leu Gln Thr Ser Gln Asp Ala Arg
1               5
</s400>
<s200>
<s210>426</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 426
Phe Tyr Ala Leu Ser Ala Ser Phe Glu Pro Phe Ser Asn Lys
1               5                   10
</s400>
<s200>
<s210>427</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 427
Ile Asp Asn Ser Gln Val Glu Ser Gly Ser Leu Glu Asp Asp Trp Asp
1               5                   10                  15
Phe Leu Pro Pro Lys Lys
            20
</s400>
<s200>
<s210>428</s210>
<s211>29</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 428
Ser Gly Thr Ile Phe Asp Asn Phe Leu Ile Thr Asn Asp Glu Ala Tyr
1               5                   10                  15
Ala Glu Glu Phe Gly Asn Glu Thr Trp Gly Val Thr Lys
            20                  25
</s400>
<s200>
<s210>429</s210>
<s211>23</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 429
Thr Asp Leu Asn Pro Asp Asn Leu Gln Gly Gly Asp Asp Leu Asp Pro
1               5                   10                  15
Asn Tyr Val Leu Ser Ser Arg
            20
</s400>
<s200>
<s210>430</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 430
Leu Ala Val Glu Ala Leu Ser Ser Leu Asp Gly Asp Leu Ala Gly Arg
1               5                   10                  15
</s400>
<s200>
<s210>431</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 431
Gly Thr Gly Gly Val Asp Thr Ala Ala Val Gly Gly Val Phe Asp Val
1               5                   10                  15
Ser Asn Ala Asp Arg
            20
</s400>
<s200>
<s210>432</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 432
Leu Gly Phe Ser Glu Val Glu Leu Val Gln Met Val Val Asp Gly Val
1               5                   10                  15
Lys
</s400>
<s200>
<s210>433</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 433
Leu Ala Asp Gly Gly Ala Thr Asn Gln Gly Arg
1               5                   10
</s400>
<s200>
<s210>434</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 434
Glu Leu Ser Glu Ala Leu Gly Gln Ile Phe Asp Ser Gln Arg
1               5                   10
</s400>
<s200>
<s210>435</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 435
Thr Leu Gln Ala Leu Glu Phe His Thr Val Pro Phe Gln Leu Leu Ala
1               5                   10                  15
Arg
</s400>
<s200>
<s210>436</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 436
Ile Tyr Thr Ser Pro Thr Trp Ser Ala Phe Val Thr Asp Ser Ser Trp
1               5                   10                  15
Ser Ala Arg
</s400>
<s200>
<s210>437</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 437
Ile Pro Gly Asp Gln Val Val Ser Val Val Phe Ile Lys
1               5                   10
</s400>
<s200>
<s210>438</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 438
Val Ile Ser Ser Gly Ser Val Ala Ser Tyr Val Thr Ser Pro Gln Gly
1               5                   10                  15
Phe Gln Phe Arg
            20
</s400>
<s200>
<s210>439</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 439
Ala Ser Tyr Ala Gln Gln Pro Ala Glu Ser Arg
1               5                   10
</s400>
<s200>
<s210>440</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 440
Ile Ala His Val Glu Leu Ala Asp Ala Gly Gln Tyr Arg
1               5                   10
</s400>
<s200>
<s210>441</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 441
Tyr Glu Leu Gly Ser Gly Leu Ala Val Leu Arg
1               5                   10
</s400>
<s200>
<s210>442</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 442
Asn Phe Ile Asn Ser Pro Val Ala Gln Ala Asp Trp Ala Ala Lys
1               5                   10                  15
</s400>
<s200>
<s210>443</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 443
Val Val Ser Ser Val Leu Gln Leu Gly Asn Ile Val Phe Lys
1               5                   10
</s400>
<s200>
<s210>444</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 444
Val Asp Tyr Asn Ala Ser Ala Trp Leu Thr Lys
1               5                   10
</s400>
<s200>
<s210>445</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 445
His Ala Gln Ala Val Glu Glu Leu Thr Glu Gln Leu Glu Gln Phe Lys
1               5                   10                  15
Arg
</s400>
<s200>
<s210>446</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 446
Asp Val Ala Ser Leu Ser Ser Gln Leu Gln Asp Thr Gln Glu Leu Leu
1               5                   10                  15
Gln Glu Glu Thr Arg
            20
</s400>
<s200>
<s210>447</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 447
Leu Gln Asp Phe Ala Ser Thr Val Glu Ala Leu Glu Glu Gly Lys
1               5                   10                  15
</s400>
<s200>
<s210>448</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 448
Glu Ile Glu Asn Leu Thr Gln Gln Tyr Glu Glu Lys
1               5                   10
</s400>
<s200>
<s210>449</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 449
Leu Gln Gln Glu Leu Asp Asp Leu Val Val Asp Leu Asp Asn Gln Arg
1               5                   10                  15
</s400>
<s200>
<s210>450</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 450
Lys Ala Thr Gln Gln Ala Glu Gln Leu Ser Asn Glu Leu Ala Thr Glu
1               5                   10                  15
Arg
</s400>
<s200>
<s210>451</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 451
Ile Ala Gln Leu Glu Glu Gln Val Glu Gln Glu Ala Arg
1               5                   10
</s400>
<s200>
<s210>452</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 452
Gln Leu Leu Gln Ala Asn Pro Ile Leu Glu Ala Phe Gly Asn Ala Lys
1               5                   10                  15
</s400>
<s200>
<s210>453</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 453
Lys Glu Glu Glu Leu Gln Ala Ala Leu Ala Arg
1               5                   10
</s400>
<s200>
<s210>454</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 454
Lys Phe Asp Gln Leu Leu Ala Glu Glu Lys
1               5                   10
</s400>
<s200>
<s210>455</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 455
Thr Gln Leu Glu Glu Leu Glu Asp Glu Leu Gln Ala Thr Glu Asp Ala
1               5                   10                  15
Lys
</s400>
<s200>
<s210>456</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 456
Leu Ala Pro Glu Tyr Glu Ala Ala Ala Thr Arg
1               5                   10
</s400>
<s200>
<s210>457</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 457
Tyr Gly Val Ser Gly Tyr Pro Thr Leu Lys
1               5                   10
</s400>
<s200>
<s210>458</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 458
Asp Gly Glu Glu Ala Gly Ala Tyr Asp Gly Pro Arg
1               5                   10
</s400>
<s200>
<s210>459</s210>
<s211>26</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 459
Phe Ile Ser Asp Lys Asp Ala Ser Ile Val Gly Phe Phe Asp Asp Ser
1               5                   10                  15
Phe Ser Glu Ala His Ser Glu Phe Leu Lys
            20                  25
</s400>
<s200>
<s210>460</s210>
<s211>24</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 460
Phe Ala His Thr Asn Val Glu Ser Leu Val Asn Glu Tyr Asp Asp Asn
1               5                   10                  15
Gly Glu Gly Ile Ile Leu Phe Arg
            20
</s400>
<s200>
<s210>461</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 461
Asp Leu Leu Ile Ala Tyr Tyr Asp Val Asp Tyr Glu Lys
1               5                   10
</s400>
<s200>
<s210>462</s210>
<s211>24</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 462
Thr Phe Ser His Glu Leu Ser Asp Phe Gly Leu Glu Ser Thr Ala Gly
1               5                   10                  15
Glu Ile Pro Val Val Ala Ile Arg
            20
</s400>
<s200>
<s210>463</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 463
Phe Leu Gln Asp Tyr Phe Asp Gly Asn Leu Lys
1               5                   10
</s400>
<s200>
<s210>464</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 464
Phe Leu Gln Asp Tyr Phe Asp Gly Asn Leu Lys Arg
1               5                   10
</s400>
<s200>
<s210>465</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 465
Ser Glu Pro Ile Pro Glu Ser Asn Asp Gly Pro Val Lys
1               5                   10
</s400>
<s200>
<s210>466</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 466
Glu Leu Ser Asp Phe Ile Ser Tyr Leu Gln Arg
1               5                   10
</s400>
<s200>
<s210>467</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 467
Phe Asp Ser Phe Thr Val Gln Tyr Lys
1               5
</s400>
<s200>
<s210>468</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 468
Leu Gly Glu Leu Trp Val Thr Asp Pro Thr Pro Asp Ser Leu Arg
1               5                   10                  15
</s400>
<s200>
<s210>469</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 469
Leu Gly Pro Ile Ser Ala Asp Ser Thr Thr Ala Pro Leu Glu Lys
1               5                   10                  15
</s400>
<s200>
<s210>470</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 470
Leu Ser Gln Leu Ser Val Thr Asp Val Thr Thr Ser Ser Leu Arg
1               5                   10                  15
</s400>
<s200>
<s210>471</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 471
Leu Phe Asp Gln Ala Phe Gly Leu Pro Arg
1               5                   10
</s400>
<s200>
<s210>472</s210>
<s211>38</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 472
Leu Pro Glu Glu Trp Ser Gln Trp Leu Gly Gly Ser Ser Trp Pro Gly
1               5                   10                  15
Tyr Val Arg Pro Leu Pro Pro Ala Ala Ile Glu Ser Pro Ala Val Ala
            20                  25                  30
Ala Pro Ala Tyr Ser Arg
        35
</s400>
<s200>
<s210>473</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 473
Val Ser Leu Asp Val Asn His Phe Ala Pro Asp Glu Leu Thr Val Lys
1               5                   10                  15
</s400>
<s200>
<s210>474</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 474
Thr Lys Asp Gly Val Val Glu Ile Thr Gly Lys
1               5                   10
</s400>
<s200>
<s210>475</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 475
Leu Ala Thr Gln Ser Asn Glu Ile Thr Ile Pro Val Thr Phe Glu Ser
1               5                   10                  15
Arg
</s400>
<s200>
<s210>476</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 476
Thr Leu Ala Gln Leu Asn Pro Glu Ser Ser Leu Phe Ile Ile Ala Ser
1               5                   10                  15
Lys
</s400>
<s200>
<s210>477</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 477
Thr Phe Thr Thr Gln Glu Thr Ile Thr Asn Ala Glu Thr Ala Lys
1               5                   10                  15
</s400>
<s200>
<s210>478</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 478
Asn Asn Gln Ile Thr Asn Asn Gln Arg
1               5
</s400>
<s200>
<s210>479</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 479
Tyr Ser Leu Glu Pro Val Ala Val Glu Leu Lys
1               5                   10
</s400>
<s200>
<s210>480</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 480
Leu Gly Asp Val Tyr Val Asn Asp Ala Phe Gly Thr Ala His Arg
1               5                   10                  15
</s400>
<s200>
<s210>481</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 481
Ala Leu Glu Ser Pro Glu Arg Pro Phe Leu Ala Ile Leu Gly Gly Ala
1               5                   10                  15
Lys
</s400>
<s200>
<s210>482</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 482
Ile Thr Leu Pro Val Asp Phe Val Thr Ala Asp Lys Phe Asp Glu Asn
1               5                   10                  15
Ala Lys
</s400>
<s200>
<s210>483</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 483
Tyr Ala Glu Ala Val Thr Arg
1               5
</s400>
<s200>
<s210>484</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 484
Gln Ile Val Trp Asn Gly Pro Val Gly Val Phe Glu Trp Glu Ala Phe
1               5                   10                  15
Ala Arg
</s400>
<s200>
<s210>485</s210>
<s211>24</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 485
Trp Asn Thr Glu Asp Lys Val Ser His Val Ser Thr Gly Gly Gly Ala
1               5                   10                  15
Ser Leu Glu Leu Leu Glu Gly Lys
            20
</s400>
<s200>
<s210>486</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 486
Ser Thr Ala Ile Ser Leu Phe Tyr Glu Leu Ser Glu Asn Asp Leu Asn
1               5                   10                  15
Phe Ile Lys
</s400>
<s200>
<s210>487</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 487
Ala Leu Leu Glu Leu Gln Leu Glu Pro Glu Glu Leu Tyr Gln Thr Phe
1               5                   10                  15
Gln Arg
</s400>
<s200>
<s210>488</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 488
Ala Arg Pro Phe Pro Asp Gly Leu Ala Glu Asp Ile Asp Lys Gly Glu
1               5                   10                  15
Val Ser Ala Arg
            20
</s400>
<s200>
<s210>489</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 489
Tyr Glu Trp Asp Val Ala Glu Ala Arg
1               5
</s400>
<s200>
<s210>490</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 490
Ala Tyr Leu Pro Val Asn Glu Ser Phe Gly Phe Thr Ala Asp Leu Arg
1               5                   10                  15
</s400>
<s200>
<s210>491</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 491
Leu Gly Glu Ile Val Thr Thr Ile Pro Thr Ile Gly Phe Asn Val Glu
1               5                   10                  15
Thr Val Glu Tyr Lys
            20
</s400>
<s200>
<s210>492</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 492
Asn Ile Ser Phe Thr Val Trp Asp Val Gly Gly Gln Asp Lys
1               5                   10
</s400>
<s200>
<s210>493</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 493
Leu Gly Glu Ile Val Thr Thr Ile Pro Thr Ile Gly Phe Asn Val Glu
1               5                   10                  15
Thr Val Glu Tyr Lys
            20
</s400>
<s200>
<s210>494</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 494
Asn Ile Ser Phe Thr Val Trp Asp Val Gly Gly Gln Asp Lys
1               5                   10
</s400>
<s200>
<s210>495</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 495
Thr Asp Tyr Asn Ala Ser Val Ser Val Pro Asp Ser Ser Gly Pro Glu
1               5                   10                  15
Arg
</s400>
<s200>
<s210>496</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 496
Ile Leu Ser Ile Ser Ala Asp Ile Glu Thr Ile Gly Glu Ile Leu Lys
1               5                   10                  15
</s400>
<s200>
<s210>497</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 497
Leu Leu Ile His Gln Ser Leu Ala Gly Gly Ile Ile Gly Val Lys
1               5                   10                  15
</s400>
<s200>
<s210>498</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 498
Ile Ile Leu Asp Leu Ile Ser Glu Ser Pro Ile Lys
1               5                   10
</s400>
<s200>
<s210>499</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 499
Ile Asp Glu Pro Leu Glu Gly Ser Glu Asp Arg
1               5                   10
</s400>
<s200>
<s210>500</s210>
<s211>23</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 500
Ile Ile Thr Ile Thr Gly Thr Gln Asp Gln Ile Gln Asn Ala Gln Tyr
1               5                   10                  15
Leu Leu Gln Asn Ser Val Lys
            20
</s400>
<s200>
<s210>501</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 501
Asp Gln Leu Ile Tyr Asn Leu Leu Lys Glu Glu Gln Thr Pro Gln Asn
1               5                   10                  15
Lys
</s400>
<s200>
<s210>502</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 502
Asp Leu Ala Asp Glu Leu Ala Leu Val Asp Val Ile Glu Asp Lys
1               5                   10                  15
</s400>
<s200>
<s210>503</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 503
Asp Leu Ala Asp Glu Leu Ala Leu Val Asp Val Ile Glu Asp Lys Leu
1               5                   10                  15
Lys
</s400>
<s200>
<s210>504</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 504
Thr Leu His Pro Asp Leu Gly Thr Asp Lys Asp Lys Glu Gln Trp Lys
1               5                   10                  15
</s400>
<s200>
<s210>505</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 505
Gln Val Val Glu Ser Ala Tyr Glu Val Ile Lys
1               5                   10
</s400>
<s200>
<s210>506</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 506
Val Thr Leu Thr Ser Glu Glu Glu Ala Arg
1               5                   10
</s400>
<s200>
<s210>507</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 507
Ser Ala Asp Thr Leu Trp Gly Ile Gln Lys
1               5                   10
</s400>
<s200>
<s210>508</s210>
<s211>6</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 508
Leu Asn Leu Val Gln Arg
1               5
</s400>
<s200>
<s210>509</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 509
Leu Val Pro Leu Leu Asp Thr Gly Asp Ile Ile Ile Asp Gly Gly Asn
1               5                   10                  15
Ser Glu Tyr Arg
            20
</s400>
<s200>
<s210>510</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 510
Gly Ile Leu Phe Val Gly Ser Gly Val Ser Gly Gly Glu Glu Gly Ala
1               5                   10                  15
Arg
</s400>
<s200>
<s210>511</s210>
<s211>23</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 511
Trp Thr Ala Ile Ser Ala Leu Glu Tyr Gly Val Pro Val Thr Leu Ile
1               5                   10                  15
Gly Glu Ala Val Phe Ala Arg
20
</s400>
<s200>
<s210>512</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 512
Phe Gln Asp Gly Asp Leu Thr Leu Tyr Gln Ser Asn Thr Ile Leu Arg
1               5                   10                  15
</s400>
<s200>
<s210>513</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 513
Asp Gln Gln Glu Ala Ala Leu Val Asp Met Val Asn Asp Gly Val Glu
1               5                   10                  15
Asp Leu Arg
</s400>
<s200>
<s210>514</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 514
Leu Pro Phe Pro Ile Ile Asp Asp Arg
1               5
</s400>
<s200>
<s210>515</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 515
Asn Phe Asp Glu Ile Leu Arg
1               5
</s400>
<s200>
<s210>516</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 516
Asn Val Thr Glu Leu Asn Glu Pro Leu Ser Asn Glu Glu Arg
1               5                   10
</s400>
<s200>
<s210>517</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 517
Tyr Leu Ala Glu Val Ala Thr Gly Glu Lys
1               5                   10
</s400>
<s200>
<s210>518</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 518
Ala Tyr Ser Glu Ala His Glu Ile Ser Lys
1               5                   10
</s400>
<s200>
<s210>519</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 519
Thr Ala Phe Asp Asp Ala Ile Ala Glu Leu Asp Thr Leu Asn Glu Asp
1               5                   10                  15
Ser Tyr Lys
</s400>
<s200>
<s210>520</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 520
Val Ala Val Leu Gly Ala Ser Gly Gly Ile Gly Gln Pro Leu Ser Leu
1               5                   10                  15
Leu Leu Lys
</s400>
<s200>
<s210>521</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 521
Ile Phe Gly Val Thr Thr Leu Asp Ile Val Arg
1               5                   10
</s400>
<s200>
<s210>522</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 522
Val Asp Phe Pro Gln Asp Gln Leu Thr Ala Leu Thr Gly Arg
1               5                   10
</s400>
<s200>
<s210>523</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 523
Ile Pro Glu Ser Gly Gly Asp Asn Ser Val Phe Asp Ile Phe Glu Leu
1               5                   10                  15
Thr Gly Ala Ala Arg
            20
</s400>
<s200>
<s210>524</s210>
<s211>23</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 524
Ile Glu Asp Ala Asn Leu Ile Pro Pro Val Pro Asp Asp Lys Phe Gln
1               5                   10                  15
Asp Leu Val Asp Ala Val Arg
            20
</s400>
<s200>
<s210>525</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 525
Gly Gly Val Asn Asp Asn Phe Gln Gly Val Leu Gln Asn Val Arg
1               5                   10                  15
</s400>
<s200>
<s210>526</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 526
Phe Val Phe Gly Thr Thr Pro Glu Asp Ile Leu Arg
1               5                   10
</s400>
<s200>
<s210>527</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 527
Thr Ile Val Thr Thr Leu Gln Asp Ser Ile Arg
1               5                   10
</s400>
<s200>
<s210>528</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 528
Gln Val Thr Gln Ser Tyr Trp Asp Thr Asn Pro Thr Arg
1               5                   10
</s400>
<s200>
<s210>529</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 529
Asn Ala Leu Trp His Thr Gly Asn Thr Pro Gly Gln Val Arg
1               5                   10
</s400>
<s200>
<s210>530</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 530
Gly Thr Tyr Ile Pro Val Pro Ile Val Ser Glu Leu Gln Ser Gly Lys
1               5                   10                  15
</s400>
<s200>
<s210>531</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 531
Lys Asp Gly Thr His Val Val Glu Asn Val Asp Ala Thr His Ile Gly
1               5                   10                  15
Lys
</s400>
<s200>
<s210>532</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 532
Asp Gly Thr His Val Val Glu Asn Val Asp Ala Thr His Ile Gly Lys
1               5                   10                  15
</s400>
<s200>
<s210>533</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 533
Phe Gln Glu Gly Gln Glu Glu Glu Arg
1               5
</s400>
<s200>
<s210>534</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 534
Ser Thr Val Leu Thr Ile Pro Glu Ile Ile Ile Lys
1               5                   10
</s400>
<s200>
<s210>535</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 535
Val Gln Asp Asp Glu Val Gly Asp Gly Thr Thr Ser Val Thr Val Leu
1               5                   10                  15
Ala Ala Glu Leu Leu Arg
            20
</s400>
<s200>
<s210>536</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 536
Leu Gly Gly Ser Leu Ala Asp Ser Tyr Leu Asp Glu Gly Phe Leu Leu
1               5                   10                  15
Asp Lys
</s400>
<s200>
<s210>537</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 537
Gly Ala Thr Gln Gln Ile Leu Asp Glu Ala Glu Arg
1               5                   10
</s400>
<s200>
<s210>538</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 538
Asp Gly Ala Gly Asp Val Ala Phe Ile Arg
1               5                   10
</s400>
<s200>
<s210>539</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 539
Ile Asp Ser Gly Leu Tyr Leu Gly Ser Gly Tyr Phe Thr Ala Ile Gln
1               5                   10                  15
Asn Leu Arg
</s400>
<s200>
<s210>540</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 540
Asp Pro Val Gln Leu Asn Leu Leu Tyr Val Gln Ala Arg
1               5                   10
</s400>
<s200>
<s210>541</s210>
<s211>26</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 541
Ala Val Ser Ser Ala Ile Ala Gln Leu Leu Gly Glu Val Ala Gln Gly
1               5                   10                  15
Asn Glu Asn Tyr Ala Gly Ile Ala Ala Arg
            20                  25
</s400>
<s200>
<s210>542</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 542
Ala Val Thr Gln Ala Leu Asn Arg
1               5
</s400>
<s200>
<s210>543</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 543
Leu Asn Glu Ala Ala Ala Gly Leu Asn Gln Ala Ala Thr Glu Leu Val
1               5                   10                  15
Gln Ala Ser Arg
            20
</s400>
<s200>
<s210>544</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 544
Thr Leu Ala Glu Ser Ala Leu Gln Leu Leu Tyr Thr Ala Lys
1               5                   10
</s400>
<s200>
<s210>545</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 545
Leu Ala Gln Ala Ala Gln Ser Ser Val Ala Thr Ile Thr Arg
1               5                   10
</s400>
<s200>
<s210>546</s210>
<s211>23</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 546
Val Gly Ala Ile Pro Ala Asn Ala Leu Asp Asp Gly Gln Trp Ser Gln
1               5                   10                  15
Gly Leu Ile Ser Ala Ala Arg
            20
</s400>
<s200>
<s210>547</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 547
Thr Gly Glu Ala Ile Val Asp Ala Ala Leu Ser Ala Leu Arg
1               5                   10
</s400>
<s200>
<s210>548</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 548
Leu Ala Ala Val Asp Ala Thr Val Asn Gln Val Leu Ala Ser Arg
1               5                   10                  15
</s400>
<s200>
<s210>549</s210>
<s211>24</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 549
Ala Leu Asp Leu Phe Ser Asp Asn Ala Pro Pro Pro Glu Leu Leu Glu
1               5                   10                  15
Ile Ile Asn Glu Asp Ile Ala Lys
            20
</s400>
<s200>
<s210>550</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 550
Asn Ser Tyr Leu Glu Val Leu Leu Lys
1               5
</s400>
<s200>
<s210>551</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 551
Gly Ser Phe Ser Glu Gln Gly Ile Asn Glu Phe Leu Arg
1               5                   10
</s400>
<s200>
<s210>552</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 552
Gly Ser Thr Ala Pro Val Gly Gly Gly Ala Phe Pro Thr Ile Val Glu
1               5                   10                  15
Arg
</s400>
<s200>
<s210>553</s210>
<s211>23</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 553
Asn Asp Phe Gln Leu Ile Gly Ile Gln Asp Gly Tyr Leu Ser Leu Leu
1               5                   10                  15
Gln Asp Ser Gly Glu Val Arg
            20
</s400>
<s200>
<s210>554</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 554
Glu Asp Leu Arg Leu Pro Glu Gly Asp Leu Gly Lys Glu Ile Glu Gln
1               5                   10                  15
Lys
</s400>
<s200>
<s210>555</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 555
Asp Gln Pro Phe Thr Ile Leu Tyr Arg
1               5
</s400>
<s200>
<s210>556</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 556
Tyr Pro Gly Ala Tyr Tyr Ile Phe Gln Ile Lys
1               5                   10
</s400>
<s200>
<s210>557</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 557
Thr Thr Pro Pro Met Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
1               5                   10                  15
Lys
</s400>
<s200>
<s210>558</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 558
Val Val Ser Val Leu Thr Val Val His Gln Asp Trp Leu Asn Gly Lys
1               5                   10                  15
</s400>
<s200>
<s210>559</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 559
Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln
1               5                   10                  15
Pro Glu Asn Asn Tyr Lys
            20
</s400>
<s200>
<s210>560</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 560
Asn Glu Asp Ser Leu Val Phe Val Gln Thr Asp Lys
1               5                   10
</s400>
<s200>
<s210>561</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 561
Ile Ala Gln Trp Gln Ser Phe Gln Leu Glu Gly Gly Leu Lys
1               5                   10
</s400>
<s200>
<s210>562</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 562
Gln Phe Ser Phe Pro Leu Ser Ser Glu Pro Phe Gln Gly Ser Tyr Lys
1               5                   10                  15
</s400>
<s200>
<s210>563</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 563
Thr Glu His Pro Phe Thr Val Glu Glu Phe Val Leu Pro Lys
1               5                   10
</s400>
<s200>
<s210>564</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 564
Phe Glu Val Gln Val Thr Val Pro Lys
1               5
</s400>
<s200>
<s210>565</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 565
Gln Gly Ile Pro Phe Phe Gly Gln Val Arg
1               5                   10
</s400>
<s200>
<s210>566</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 566
Leu Leu Ile Tyr Ala Val Leu Pro Thr Gly Asp Val Ile Gly Asp Ser
1               5                   10                  15
Ala Lys
</s400>
<s200>
<s210>567</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 567
Val Ser Val Gln Leu Glu Ala Ser Pro Ala Phe Leu Ala Val Pro Val
1               5                   10                  15
Glu Lys
</s400>
<s200>
<s210>568</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 568
Asp Thr Val Ile Lys Pro Leu Leu Val Glu Pro Glu Gly Leu Glu Lys
1               5                   10                  15
</s400>
<s200>
<s210>569</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 569
Leu Pro Pro Asn Val Val Glu Glu Ser Ala Arg
1               5                   10
</s400>
<s200>
<s210>570</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 570
Ala Ile Gly Tyr Leu Asn Thr Gly Tyr Gln Arg
1               5                   10
</s400>
<s200>
<s210>571</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 571
Thr Ala Gln Glu Gly Asp His Gly Ser His Val Tyr Thr Lys
1               5                   10
</s400>
<s200>
<s210>572</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 572
Ala Leu Leu Ala Tyr Ala Phe Ala Leu Ala Gly Asn Gln Asp Lys
1               5                   10                  15
</s400>
<s200>
<s210>573</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 573
Phe Gln Val Asp Asn Asn Asn Arg
1               5
</s400>
<s200>
<s210>574</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 574
Val Ser Asn Gln Thr Leu Ser Leu Phe Phe Thr Val Leu Gln Asp Val
1               5                   10                  15
Pro Val Arg
</s400>
<s200>
<s210>575</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 575
Asn Gln Gly Asn Thr Trp Leu Thr Ala Phe Val Leu Lys
1               5                   10
</s400>
<s200>
<s210>576</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 576
Ser Ser Gly Ser Leu Leu Asn Asn Ala Ile Lys
1               5                   10
</s400>
<s200>
<s210>577</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 577
Tyr Gly Ala Ala Thr Phe Thr Arg
1               5
</s400>
<s200>
<s210>578</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 578
Glu Lys Pro Tyr Phe Pro Ile Pro Glu Glu Tyr Thr Phe Ile Gln Asn
1               5                   10                  15
Val Pro Leu Glu Asp Arg
            20
</s400>
<s200>
<s210>579</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 579
Asn Phe Ile Leu Asp Gln Thr Asn Val Ser Ala Ala Ala Gln Arg
1               5                   10                  15
</s400>
<s200>
<s210>580</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 580
His Gly Glu Ser Ala Trp Asn Leu Glu Asn Arg
1               5                   10
</s400>
<s200>
<s210>581</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 581
Ala Leu Pro Phe Trp Asn Glu Glu Ile Val Pro Gln Ile Lys
1               5                   10
</s400>
<s200>
<s210>582</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 582
Gln Met Glu Gln Ile Ser Gln Phe Leu Gln Ala Ala Glu Arg
1               5                   10
</s400>
<s200>
<s210>583</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 583
Tyr Gly Ile Asn Thr Thr Asp Ile Phe Gln Thr Val Asp Leu Trp Glu
1               5                   10                  15
Gly Lys
</s400>
<s200>
<s210>584</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 584
Asp Asp Gly Leu Phe Ser Gly Asp Pro Asn Trp Phe Pro Lys
1               5                   10
</s400>
<s200>
<s210>585</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 585
Asn Phe Ser Asp Asn Gln Leu Gln Glu Gly Lys
1               5                   10
</s400>
<s200>
<s210>586</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 586
Val Thr Val Leu Gly Gln Pro Lys
1               5
</s400>
<s200>
<s210>587</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 587
Ala Asn Pro Thr Val Thr Leu Phe Pro Pro Ser Ser Glu Glu Leu Gln
1               5                   10                  15
Ala Asn Lys
</s400>
<s200>
<s210>588</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 588
Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg
1               5                   10                  15
</s400>
<s200>
<s210>589</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 589
Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
1               5                   10                  15
</s400>
<s200>
<s210>590</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 590
Leu Val Ile Thr Gly Asn Leu Ile Thr Ile Phe Gln Glu Arg
1               5                   10
</s400>
<s200>
<s210>591</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 591
Leu Ile Ser Trp Tyr Asp Asn Glu Phe Gly Tyr Ser Asn Arg
1               5                   10
</s400>
<s200>
<s210>592</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 592
Thr Phe Asp Gly Asp Val Phe Arg
1               5
</s400>
<s200>
<s210>593</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 593
Ala Ala Tyr Glu Asp Phe Asn Val Gln Leu Arg
1               5                   10
</s400>
<s200>
<s210>594</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 594
Leu Thr Pro Leu Gln Phe Gly Asn Leu Gln Lys
1               5                   10
</s400>
<s200>
<s210>595</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 595
Leu Thr Asp Pro Asn Ser Ala Phe Ser Arg
1               5                   10
</s400>
<s200>
<s210>596</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 596
Leu Phe Val Glu Ser Tyr Glu Leu Ile Leu Gln Glu Gly Thr Phe Lys
1               5                   10                  15
</s400>
<s200>
<s210>597</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 597
Ser Val Val Gly Asp Ala Leu Glu Phe Gly Asn Ser Trp Lys
1               5                   10
</s400>
<s200>
<s210>598</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 598
Ser Glu Gln Leu Gly Gly Asp Val Glu Ser Tyr Asp Lys
1               5                   10
</s400>
<s200>
<s210>599</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 599
Glu Glu Gly Leu Ile Leu Phe Asp Gln Ile Pro Val Ser Ser Gly Phe
1               5                   10                  15
Ser Lys
</s400>
<s200>
<s210>600</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 600
Val Asp Ile Pro Ala Leu Gly Val Ser Val Thr Phe Asn Gly Gln Val
1               5                   10                  15
Phe Gln Ala Arg
20
</s400>
<s200>
<s210>601</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 601
Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys
1               5                   10
</s400>
<s200>
<s210>602</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 602
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
1               5                   10                  15
</s400>
<s200>
<s210>603</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 603
Gly Leu Glu Trp Val Ala Asn Ile Lys
1               5
</s400>
<s200>
<s210>604</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 604
Ala Leu Gln Ala Thr Val Gly Asn Ser Tyr Lys
1               5                   10
</s400>
<s200>
<s210>605</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 605
Gly Ser Phe Thr Tyr Phe Ala Pro Ser Asn Glu Ala Trp Asp Asn Leu
1               5                   10                  15
Asp Ser Asp Ile Arg
            20
</s400>
<s200>
<s210>606</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 606
Ile Ile His Gly Asn Gln Ile Ala Thr Asn Gly Val Val His Val Ile
1               5                   10                  15
Asp Arg
</s400>
<s200>
<s210>607</s210>
<s211>23</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 607
Val Leu Thr Gln Ile Gly Thr Ser Ile Gln Asp Phe Ile Glu Ala Glu
1               5                   10                  15
Asp Asp Leu Ser Ser Phe Arg
            20
</s400>
<s200>
<s210>608</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 608
Ala Ala Ala Ile Thr Ser Asp Ile Leu Glu Ala Leu Gly Arg
1               5                   10
</s400>
<s200>
<s210>609</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 609
Asp Gly His Phe Thr Leu Phe Ala Pro Thr Asn Glu Ala Phe Glu Lys
1               5                   10                  15
</s400>
<s200>
<s210>610</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 610
Asp Ile Val Thr Asn Asn Gly Val Ile His Leu Ile Asp Gln Val Leu
1               5                   10                  15
Ile Pro Asp Ser Ala Lys
            20
</s400>
<s200>
<s210>611</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 611
Val Gly Leu Asn Glu Leu Tyr Asn Gly Gln Ile Leu Glu Thr Ile Gly
1               5                   10                  15
Gly Lys
</s400>
<s200>
<s210>612</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 612
Phe Ser Thr Phe Leu Ser Leu Leu Glu Ala Ala Asp Leu Lys
1               5                   10
</s400>
<s200>
<s210>613</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 613
Leu Leu Tyr Pro Ala Asp Thr Pro Val Gly Asn Asp Gln Leu Leu Glu
1               5                   10                  15
Ile Leu Asn Lys
            20
</s400>
<s200>
<s210>614</s210>
<s211>23</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 614
Ala Gly Ala Ala Pro Tyr Val Gln Ala Phe Asp Ser Leu Leu Ala Gly
1               5                   10                  15
Pro Val Ala Glu Tyr Leu Lys
            20
</s400>
<s200>
<s210>615</s210>
<s211>18</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 615
Val Glu Asn Gln Glu Asn Val Ser Asn Leu Val Ile Glu Asp Thr Glu
1               5                   10                  15
Leu Lys
</s400>
<s200>
<s210>616</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 616
Glu Val Ser Gln Pro Asp Trp Thr Pro Pro Pro Glu Val Thr Leu Val
1               5                   10                  15
Leu Thr Lys
</s400>
<s200>
<s210>617</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 617
Val Asp Ala Thr Ala Glu Thr Asp Leu Ala Lys
1               5                   10
</s400>
<s200>
<s210>618</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 618
Ile Ala Asp Gly Tyr Glu Gln Ala Ala Arg
1               5                   10
</s400>
<s200>
<s210>619</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 619
Trp Val Gly Gly Pro Glu Ile Glu Leu Ile Ala Ile Ala Thr Gly Gly
1               5                   10                  15
Arg
</s400>
<s200>
<s210>620</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 620
Leu Gly Phe Ala Gly Leu Val Gln Glu Ile Ser Phe Gly Thr Thr Lys
1               5                   10                  15
</s400>
<s200>
<s210>621</s210>
<s211>20</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 621
Glu Ile Ser Pro Asp Thr Thr Leu Leu Asp Leu Gln Asn Asn Asp Ile
1               5                   10                  15
Ser Glu Leu Arg
            20
</s400>
<s200>
<s210>622</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 622
Glu Ile Ser Pro Asp Thr Thr Leu Leu Asp Leu Gln Asn Asn Asp Ile
1               5                   10                  15
Ser Glu Leu Arg Lys
            20
</s400>
<s200>
<s210>623</s210>
<s211>14</s211>
<s212>PRT</s212>
<s213>artificial</s213>
<s220>
<s223>peptide fragment present in lectin-bound
      fraction isolated from human ovarian tumors</s223>
</s220>
</s200>
<s400> 623
Gly Leu Gln His Leu Tyr Ala Leu Val Leu Val Asn Asn Lys
1               5                   10
</s400>
</sequence-list-new-rules>
</sequence-cwu>
